前往化源商城

67-96-9 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Gamma-aminobutyric acid receptor subunit alpha-1
External ID: CHEMBL5291801
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL343
ChEMBL Target Name: GABA receptor alpha-1 subunit
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.0041AC50=4.1nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.0106AC50=10.6nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Gamma-aminobutyric acid receptor subunit alpha-1
External ID: CHEMBL5291798
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL343
ChEMBL Target Name: GABA receptor alpha-1 subunit
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Estrogen receptor
External ID: CHEMBL5291791
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL206
ChEMBL Target Name: Estrogen receptor alpha
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
1.0E-4AC50=0.1nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:N/A
External ID: TRND-SARS-CoV-2-cytotox-48hr
Protocol: PROTOCOL TABLE
SEQUENCE No. (e.g., 1, 2, 3, etc.); PARAMETER (e.g., Cells, Incubation, Reagent, etc.); VALUE and DESCRIPTION.
1. Cells. Seed 1500 HEK293-ACE2 cells (Expi293F with stable expression of human ACE2) in 2 uL/well media (DMEM, 10% FBS, 1x L-glutamine, 1x Pen/Strep, 1 ug/ml puromycin) in white 1536-well assay plates (Greiner #782073).
2. Incubation. Incubate at 37 C with 5% CO2 overnight (~16 h).
3. Compounds. Dispense 23 nL/well compounds in DMSO via pin transfer.
4. Incubation. Incubate for 1 h at 37C 5% CO2.
5. Reagent. Dispense 2 uL/well of media (DMEM, 10% FBS, 1x L-glutamine, 1x Pen/Strep, 1 ug/ml puromycin).
6. Incubation. Incubate at for 48h at 37C 5% CO2
7. Reagent. Dispense 4 uL/well of ATPLite 1step luminescence assay reagent (PerkinElmer #6016739).
8. Incubation. Incubate for 15 min at room temperature.
9. Detection. Read luminescence signal (Viewlux plate reader, PerkinElmer). Data was normalized with wells containing cells as 100%, and wells without cells (media only control) as 0%.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent cytotoxic compounds are ranked higher than compounds that showed no activity.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = -1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 || ratio.curve_class == -2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.00457 uMActivity at 0.00705 uMActivity at 0.023 uMActivity at 0.046 uMActivity at 0.070 uMActivity at 0.104 uMActivity at 0.147 uMActivity at 0.228 uMActivity at 0.454 uMActivity at 0.702 uMActivity at 0.990 uMActivity at 1.179 uMActivity at 2.205 uMActivity at 3.547 uMActivity at 5.245 uMActivity at 6.528 uMActivity at 11.35 uMActivity at 18.98 uMActivity at 27.12 uMActivity at 37.89 uMActivity at 57.10 uMActivity at 85.70 uMActivity at 114.4 uMActivity at 171.0 uMCompound QC
Cytotoxic2.511989.96385Complete curve; high efficacy-5.62.40640.9988-81.9638-1.10 0 0 0-81.02564.3424-26.1944-82.8623-81.0256QC'd by MedChem Express
Cytotoxic3.162394.537785Complete curve; high efficacy-5.54.50450.9999-94.32250.2153-1.10 0 0 0-94.7013-0.2373-13.1526-93.6408-94.7013QC'd by SIGMA
Cytotoxic2.818494.81785Complete curve; high efficacy-5.552.04790.9999-95.8221-1.005-1.10 0 0 0-95.0616-6.2542-35.3146-94.5292-95.0616QC'd by APExBIO
Cytotoxic2.818490.520785Complete curve; high efficacy-5.553.06540.9989-88.52072-1.10 0 0 0-86.88350-24.056-89.9601-86.8835QC'd by MedChem Express
Cytotoxic5.623496.974284Complete curve; high efficacy-5.254.0951-95.47421.5-1.10 0 0 0-95.85761.65590-94.7507-95.8576QC'd by SynKinase
Cytotoxic3.981196.100684Complete curve; high efficacy-5.44.50451-95.10061-1.10 0 0 0-94.91080.5692-4.2795-94.8159-94.9108QC'd by Tocris
Cytotoxic2.511977.656384Complete curve; high efficacy-5.62.04790.9997-80.7421-3.0858-1.10 0 0 0-80.0369-5.0715-39.0219-77.613-80.0369QC'd by Microsource
Cytotoxic7.943399.498683Complete curve; high efficacy-5.14.95490.9997-96.99862.5-1.10 0 0 0-96.8051.23063.5418-95.9316-96.805QC'd by MedChem Express
Cytotoxic7.079597.835883Complete curve; high efficacy-5.154.95490.9993-95.83582-1.10 0 0 0-95.644503.4249-95.1788-95.6445QC'd by Tocris
Cytotoxic7.079597.375183Complete curve; high efficacy-5.154.0951-97.37510-1.10 0 0 0-97.18070-0.6843-95.5282-97.1807QC'd by MedChem Express
Cytotoxic7.0795102.439983Complete curve; high efficacy-5.151.69240.9998-100.43992-1.10 0 0 0-96.76290-9.8984-85.0051-96.7629QC'd by MedChem Express
Cytotoxic7.079596.356883Complete curve; high efficacy-5.154.95491-96.35680-1.10 0 0 0-96.164400-95.5939-96.1644QC'd by MedChem Express
Cytotoxic7.079593.612783Complete curve; high efficacy-5.154.95491-93.61270-1.10 0 0 0-93.425800-92.8807-93.4258QC'd by MedChem Express
Cytotoxic8.912597.135783Complete curve; high efficacy-5.054.95491-97.13570-1.10 0 0 0-96.941800-94.9322-96.9418QC'd by APExBIO
Cytotoxic8.9125105.03483Complete curve; high efficacy-5.051.64360.9999-100.0345-1.10 0 0 0-94.72923.0536-3.9173-76.9038-94.7292QC'd by Glixx
Cytotoxic1091.303782Complete curve; high efficacy-52.18761-85.80375.5-1.10 0 0 0-84.12124.86462.5388-67.7158-84.1212QC'd by SIGMA
Cytotoxic1098.125282Complete curve; high efficacy-52.84730.9999-97.62520.5-1.10 0 0 0-96.850400-83.9555-96.8504QC'd by Cayman
Cytotoxic11.220293.877282Complete curve; high efficacy-4.952.40640.9998-92.87721-1.10 0 0 0-91.056100-72.1776-91.0561QC'd by Selleck
Cytotoxic0.891360.234867Complete curve; partial efficacy-6.053.51170.9985-93.1767-32.9418-1.20 0 0 0-93.5509-51.1212-90.8041-91.9137-93.5509QC'd by Selleck
Cytotoxic0.794356.680267Complete curve; partial efficacy-6.13.92950.9999-91.2497-34.5695-1.20 0 0 0-91.0675-40.2642-90.3425-90.8279-91.0675QC'd by MedChem Express
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: TRND-SARS-CoV-2-PP
Protocol: PROTOCOL TABLE (format as described by Inglese J, Shamu CE and Guy RK. 2007)
SEQUENCE No. (e.g., 1, 2, 3, etc.); PARAMETER (e.g., Cells, Incubation, Reagent, etc.); VALUE and DESCRIPTION.

1. Cells. Seed 1500 HEK293-ACE2 cells (Expi293F with stable expression of human ACE2) in 2 uL/well media (DMEM, 10% FBS, 1x L-glutamine, 1x Pen/Strep, 1 ug/ml puromycin) in white 1536-well assay plates (Greiner #782073).
2. Incubation. Incubate at 37C with 5% CO2 overnight (~16 h).
3. Compounds. Dispense 23 nL/well compounds in DMSO via pin transfer.
4. Incubation. Incubate for 1 hr at 37C 5% CO2.
5. Reagent. Dispense 2 uL/well of SARS-CoV-2-S pseudotyped particles. [a] PPs are produced with murine leukemia virus pseudotyping. [b] SARS-CoV-2-S is Wuhan-Hu-1 sequence (BEI #NR-52420) with C-terminal 19 amino acid truncation.
6. Centrifuge. Spin-inoculate by centrifugation at 1500 rpm (453 xg) for 45 min at room temperature.
7. Incubation. Incubate at for 48 hr at 37C 5% CO2
8. Centrifuge. Remove supernatant with gentle centrifugation using a Blue Washer (BlueCat Bio).
9. Reagent. Dispense 4 uL/well of Bright-Glo Luciferase detection reagent (Promega #E2620).
10. Incubation. Incubate for 5 min at room temperature.
11. Detection. Read luminescence signal (Viewlux plate reader, PerkinElmer). Data was normalized with wells containing SARS-CoV-2-S PP as 100%, and wells containing bald PP (no fusion protein) as 0%.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = -1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 || ratio.curve_class == -2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.00457 uMActivity at 0.00705 uMActivity at 0.023 uMActivity at 0.046 uMActivity at 0.070 uMActivity at 0.104 uMActivity at 0.147 uMActivity at 0.228 uMActivity at 0.454 uMActivity at 0.702 uMActivity at 0.990 uMActivity at 1.179 uMActivity at 2.205 uMActivity at 3.547 uMActivity at 5.245 uMActivity at 6.528 uMActivity at 11.35 uMActivity at 18.98 uMActivity at 27.12 uMActivity at 37.89 uMActivity at 57.10 uMActivity at 85.70 uMActivity at 114.4 uMActivity at 171.0 uMCompound QC
Inhibitor0.707934.828810Complete curve; partial efficacy; poor fit-6.154.95490.7525-34.81130.0174-1.40 0 0 0-43.6793-3.7355-37.8905-22.6342-43.6793QC'd by MedChem Express
Inhibitor35.481336.764810Single point of activity-4.452.40640.8748-40.7648-4-30 0 0 0-31.8873-11.45960-6.0521-31.8873QC'd by Pharmaron
Inhibitor39.810740.392710Single point of activity-4.44.44950.7948-48.5731-8.1804-30 0 0 0-41.7275-5.1127-20.8986-3.4837-41.7275QC'd by FLUKA
Inhibitor39.810736.302110Single point of activity-4.44.44950.9302-39.3021-3-30 0 0 0-33.1684-8.76590-0.1246-33.1684QC'd by Prestwick
Inhibitor1091.825410Partial curve; high efficacy; poor fit-53.92951-91.32540.5-2.31 0 0 0-91.1431-30.0380-57.0259-91.1431QC'd by APExBIO
Inhibitor39.810788.872610Single point of activity-4.44.95490.9981-87.87261-30 0 0 0-75.3105003.3645-75.3105QC'd by Microsource
Inhibitor39.810739.07410Single point of activity-4.44.95490.9982-38.5740.5-30 0 0 0-32.9783001.4313-32.9783QC'd by Carbosynth
Inhibitor17.782845.659310Partial curve; partial efficacy; poor fit-4.751.96730.9887-54.3257-8.6664-2.40 0 0 0-50.2467-11.0836-6.8054-21.6158-50.2467QC'd by TargetMol
Inhibitor39.810774.978610Single point of activity-4.44.44950.9815-77.9786-3-30 0 0 0-65.3989-8.931700-65.3989QC'd by MedChem Express
Inhibitor39.810735.78810Single point of activity-4.44.44950.945-39.8408-4.0529-30 0 0 0-34.034-8.1712-5.8755-0.0441-34.034QC'd by Adooq
Inhibitor19.952698.547510Partial curve; high efficacy; poor fit-4.71.96730.9936-101.5475-3-2.30 0 0 0-90.5058-6.67020-28.4282-90.5058QC'd by MedChem Express
Inhibitor39.810794.209610Partial curve; high efficacy; poor fit-4.44.44950.9731-106.3898-12.1802-2.30 0 0 0-90.4675-6.8168-21.693-10.2877-90.4675QC'd by Axon Medchem
Inhibitor39.810768.339410Single point of activity-4.44.95490.8933-61.33947-30 0 0 0-51.53290021.3412-51.5329QC'd by MedChem Express
Inhibitor11.220245.057510Partial curve; partial efficacy; poor fit-4.951.85790.9996-42.55752.5-2.41 0 0 0-40.794-21.67980-20.0057-40.794QC'd by MedChem Express
Inhibitor22.3872113.332310Partial curve; high efficacy; poor fit-4.651.69241-111.33232-2.31 0 0 0-91.8583-33.87930-25.3979-91.8583QC'd by Microsource
Inhibitor7.079544.4210Single point of activity-5.154.95490.6152-48.42-4-30 0 0 0-44.8333-14.7954-20.3760-44.8333QC'd by SIGMA
Inhibitor39.810732.918510Single point of activity-4.44.95490.6127-36.9185-4-30 0 0 0-32.01542.7163-20.08280-32.0154QC'd by Selleck
Inhibitor39.810751.184410Single point of activity-4.44.44951-51.18440-30 0 0 0-42.6537000-42.6537QC'd by MedChem Express
Inhibitor1058.179910Partial curve; partial efficacy; poor fit-53.51170.9887-59.1799-1-2.40 0 0 0-59.8069-4.87472.0564-35.7833-59.8069QC'd by DC Chemicals
Inhibitor39.810740.290110Single point of activity-4.44.44950.7334-45.6865-5.3964-30 0 0 0-38.9054-16.4277-13.0282-1.1636-38.9054QC'd by Adooq
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:D(2) dopamine receptor
External ID: CHEMBL5291781
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL217
ChEMBL Target Name: Dopamine D2 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
3.2AC50=3200nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
1.3AC50=1300nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.98AC50=980nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.39AC50=390nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:D(1A) dopamine receptor
External ID: CHEMBL5291777
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL2056
ChEMBL Target Name: Dopamine D1 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Cannabinoid receptor 1
External ID: CHEMBL5291773
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL218
ChEMBL Target Name: Cannabinoid CB1 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.1739AC50=173.9nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Melanocortin receptor 4
External ID: CHEMBL5291832
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL259
ChEMBL Target Name: Melanocortin receptor 4
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
21.3998AC50=21399.8nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
33.3803AC50=33380.3nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac1-activator-f1f2f3f4
Protocol: Briefly, three uL of reagents (100 nM EPAC1, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control of 6.5 mM cAMP.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = 1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 || ratio.curve_class == 2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds also have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0008905393 uMActivity at 0.00133 uMActivity at 0.00260 uMActivity at 0.00420 uMActivity at 0.00779 uMActivity at 0.011 uMActivity at 0.023 uMActivity at 0.033 uMActivity at 0.070 uMActivity at 0.092 uMActivity at 0.148 uMActivity at 0.213 uMActivity at 0.447 uMActivity at 0.637 uMActivity at 1.271 uMActivity at 1.910 uMActivity at 3.487 uMActivity at 5.719 uMActivity at 10.47 uMActivity at 17.11 uMActivity at 29.50 uMActivity at 51.33 uMActivity at 83.48 uMActivity at 153.7 uMActivity at 271.3 uMActivity at 313.8 uMCompound QC
Inactive0-4.210.854215-0.814140 0 0 0 0 0 0 012.47610.61490.1958-4.84511.0169-0.16650.92927.32412.4761QC'd by Chem Div
Inactive00045.5368-0.1521-0.48530.81233.044.35085.5368QC'd by Chem Div
Inactive00048.60424.86186.00054.85722.40882.55011.87353.33368.6042QC'd by Chem Div
Inactive0004-2.88031.5268-0.8493-0.86114.1068-1.778-0.0897-1.4954-2.8803QC'd by Chem Div
Inactive00046.69795.85144.53873.26556.71933.13773.82684.83146.6979QC'd by Chem Div
Inactive000411.26423.91961.89474.75392.74994.395111.2642QC'd by Chem Div
Inactive00044.34292.9262-0.18853.24881.5027-2.50024.3429QC'd by Chem Div
Inactive0004-0.68293.35561.39732.46983.71382.6913-0.6829QC'd by DPISMR
Inactive00044.10942.9782.9594-0.21373.96293.24447.01052.24494.1094QC'd by ChemBridge
Inactive0-3.910.7748300.685240 0 0 0 0 0 0 023.31094.92231.4858-0.26241.7621-0.08891.75686.642923.3109QC'd by ChemBridge
Inactive00047.22591.12572.50452.1182.1360.31087.2259QC'd by DPISMR
Inactive00042.76816.76342.22783.34190.98461.31152.76713.38112.7681QC'd by ChemBridge
Inactive0-4.110.842918-0.163240 0 0 0 0 0 0 013.83342.76191.5007-1.44281.3099-2.6361.86187.598213.8334QC'd by ChemBridge
Inactive00045.8128-3.60751.45912.0274-0.4652-4.9165.8128QC'd by ChemBridge
Inactive0-3.9510.7398-12.738-0.540 0 0 0 0 0-8.9483-1.7034-0.1105-2.14621.7984-5.297-8.9483QC'd by ChemBridge
Inactive0004-2.5811-8.353-2.4919-8.4727-4.4155-5.0949-1.5077-0.4001-2.5811QC'd by ChemBridge
Inactive0-4.4510.7869-2940 0 0 0 0 0 0 00.175111.52147.2935.777410.98237.5586.131.27520.1751QC'd by ChemBridge
Inactive0-3.9510.844324-0.688340 0 0 0 0 0 0 017.1313-1.35951.4567-3.49020.35182.67021.93716.15817.1313QC'd by ChemBridge
Inactive0-6.6510.43633-6.18840 0 0 0 0 07.2613-3.491.14993.89341.143-1.03677.2613QC'd by ChemBridge
Inactive00.60.956-7.38787.540 0 0 0 0 0 0 0 0 0 0-7.40656.37485.78158.52675.20314.23673.0265-1.7308-2.2978-3.391-4.7307-7.4065QC'd by Microsource
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC167MG
Protocol: Tox21 Assay Protocol Summary:

5 uL of culture medium (DMEM containing 10% FBS) per well was dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). After 23 nL compound or DMSO vehicle was transferred into assay plate by a pintool work station (Kalypsys, San Diego, CA), fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive040.10310.1406-0.03150.12620.060.1031QC'd by "NCI"0
Inactive040.02-0.0462-0.0096-0.0036-0.06880.02QC'd by "NCI"0
Inactive040.0352-0.02430.01330.08820.02270.0352QC'd by "NCI"0
Inactive04-0.0032-0.14120.03560.0067-0.0827-0.0032QC'd by "SigmaAldrich"0
Inactive04-0.0421-6.0E-4-0.01160.00418.0E-4-0.0421QC'd by "NCI"0
Inactive04-0.08870.05490.011900.0103-0.0887QC'd by "NCI"0
Inactive040.05490.14040.09660.0264-0.00150.0549QC'd by "NCI"0
Inactive04-0.0674-0.0024-0.1251-0.0771-0.0044-0.0674QC'd by "NCI"0
Inactive040.07660.11210.11820.1033-0.02320.0766QC'd by "NCI"0
Inactive040.02350.0289-0.01920.0237-0.01010.0235QC'd by "Labotest"0
Inactive04-1.0E-40.04880.0010.01740.0628-1.0E-4QC'd by "NCI"0
Inactive04-0.00820.10220.09650.07640.0317-0.0082QC'd by "NCI"0
Inactive040.04070.1229-0.00830.10480.07010.0407QC'd by "NCI"0
Inactive04-0.0682-0.10260.0427-0.0797-0.01-0.0682QC'd by "NCI"0
Inactive04-0.01790.0067-0.06430.0889-0.0161-0.0179QC'd by "NCI"0
Inactive04-0.0027-0.0933-0.0538-0.0212-0.0192-0.0027QC'd by "NCI"0
Inactive04-0.0156-0.0199-0.013-0.0358-0.0233-0.0156QC'd by "NCI"0
Inactive040.03220.01980.0576-0.00580.03020.0322QC'd by "Chembridge"0
Inactive040.10750.08580.07490.0633-0.01660.1075QC'd by "NCI"0
Inactive04-0.186-0.0569-0.018-0.0052-0.0633-0.186QC'd by "NCI"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Melanocortin receptor 3
External ID: CHEMBL5291831
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL4644
ChEMBL Target Name: Melanocortin receptor 3
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
18.8001AC50=18800.1nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
27.4101AC50=27410.1nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac1-inhibitor-f1f2f3f4
Protocol: Briefly, three uL of reagents (100 nM EPAC1, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control ATA and DMSO.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = 1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 || ratio.curve_class == 2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds also have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0006653454 uMActivity at 0.0009950977 uMActivity at 0.00194 uMActivity at 0.00314 uMActivity at 0.00582 uMActivity at 0.00823 uMActivity at 0.017 uMActivity at 0.024 uMActivity at 0.052 uMActivity at 0.069 uMActivity at 0.111 uMActivity at 0.159 uMActivity at 0.334 uMActivity at 0.476 uMActivity at 0.949 uMActivity at 1.427 uMActivity at 2.605 uMActivity at 4.273 uMActivity at 7.820 uMActivity at 12.78 uMActivity at 22.04 uMActivity at 38.35 uMActivity at 62.38 uMActivity at 114.8 uMActivity at 202.7 uMActivity at 234.5 uMCompound QC
Inhibitor3.141491.565384Complete curve; high efficacy-5.50291.10.996-83.56538-1.10 0 0 0 0 0 0 0 0 0 0-83.39855.86425.17526.892210.90315.38042.223-20.9811-45.6671-65.9774-77.4953-83.3985QC'd by SigmaAldrich
Inhibitor7.568673.19383Complete curve; high efficacy-5.1211.78850.9952-82.8887-9.6957-1.10 0 0 0 0 0 0 0-80.375-9.2369-7.6804-7.6509-14.8323-17.372-58.9614-82.7971-80.375QC'd by Chem Div
Inhibitor9.5283113.41783Complete curve; high efficacy-5.0212.04790.9957-126.8199-13.4029-1.10 0 0 0 0 0 0 0-128.8821-12.2785-9.679-19.3504-12.0769-19.5794-82.8273-119.9921-128.8821QC'd by Asinex Ltd.
Inhibitor8.912597.094183Complete curve; high efficacy-5.051.41630.9972-95.91371.1804-1.10 0 0 0 0 0-95.1525-2.22623.0431-10.9978-55.3438-87.9728-95.1525QC'd by Key Organics Ltd.
Inhibitor7.568680.84283Complete curve; high efficacy-5.1211.86170.99-94.8681-14.0261-1.10 0 0 0 0 0 0 0-88.9598-9.2218-14.3086-16.5014-16.2031-22.3172-68.1032-98.8209-88.9598QC'd by Sigma Chemical Company
Inhibitor9.5283107.83683Complete curve; high efficacy-5.0210.80.9912-121.2518-13.4158-1.10 0 0 0 0 0 0 0-109.8296-16.8462-9.939-19.9812-16.655-43.876-69.7913-99.6793-109.8296QC'd by Asinex Ltd.
Inhibitor9.5283102.410283Complete curve; high efficacy-5.0212.25260.9928-112.0345-9.6243-1.10 0 0 0 0 0 0 0-116.7026-13.4215-5.2335-14.5215-9.9722-10.6725-70.1375-106.0787-116.7026QC'd by InterBioScreen
Inhibitor6.7456100.747783Complete curve; high efficacy-5.1712.04790.9883-102.4434-1.6957-1.10 0 0 0 0 0 0 0-110.1541-0.6199-3.1798-6.28492.8918-11.5064-77.2529-92.783-110.1541QC'd by InterBioScreen
Inhibitor8.4921112.57283Complete curve; high efficacy-5.0712.04790.9978-114.9669-2.3949-1.10 0 0 0 0 0 0 0-112.6964-0.4977-0.1079-6.8481-0.5406-11.4336-76.2713-113.3796-112.6964QC'd by Chem Div
Inhibitor9.5283100.648483Complete curve; high efficacy-5.0211.78850.9962-100.64840-1.10 0 0 0 0 0 0 0-102.91253.22740.2085-3.8063-2.2579-5.9804-58.4009-93.2587-102.9125QC'd by InterBioScreen
Inhibitor7.032775.807582Complete curve; high efficacy-5.15291.210.9887-67.80758-1.10 0 0 0 0 0 0 0 0 0 0-62.73296.41369.1587.55816.57045.82533.26394.0875-18.7337-46.8788-54.1698-62.7329QC'd by Timtec
Inhibitor9.528377.680982Complete curve; high efficacy-5.0211.22210.9944-83.7222-6.0413-1.10 0 0 0 0 0 0 0-81.7738-4.3587-3.5127-10.8793-7.6754-16.5948-51.1312-73.833-81.7738QC'd by InterBioScreen
Inhibitor10.69175.705882Complete curve; high efficacy-4.9711.96730.9723-81.5585-5.8527-1.10 0 0 0 0 0 0 0-71.231-3.7858-1.8418-9.4119-9.4119-9.0819-46.725-88.2668-71.231QC'd by Chem Div
Inhibitor6.01299.425582Complete curve; high efficacy-5.2210.40.9552-66.407633.018-1.10 0 0 0 0 0 0 0-48.549732.930223.856811.2161.8455-3.1495-12.7102-42.9961-48.5497QC'd by InterBioScreen
Inhibitor12.589384.403582Complete curve; high efficacy-4.92.72020.9858-86.2417-1.8382-1.10 0 0 0 0 0-85.6842.3129-10.93951.6385-38.1285-86.0696-85.684QC'd by Nathanael S Gray - Dana Farber Cancer Institute - MLI PSL
Inhibitor12.589381.614682Complete curve; high efficacy-4.92.33320.999-91.3016-9.687-1.10 0 0 0 0 0-91.1194-8.8096-11.8548-10.1481-45.0265-88.9937-91.1194QC'd by InterBioScreen
Inhibitor13.459186.958882Complete curve; high efficacy-4.8711.46410.9849-93.9971-7.0383-1.10 0 0 0 0 0 0 0-84.5472-4.3953-7.2317-9.2129-14.3512-7.0393-45.0179-87.0343-84.5472QC'd by InterBioScreen
Inhibitor8.912591.139782Complete curve; high efficacy-5.054.0950.9946-89.05642.0833-1.10 0 0 0 0 0-93.35055.8165-1.44992.1549-65.2799-85.2894-93.3505QC'd by Enamine
Inhibitor15.101490.259882Complete curve; high efficacy-4.8212.40640.9711-110.2608-20.001-1.10 0 0 0 0 0 0 0-98.3869-17.9349-21.0527-21.4562-23.8802-18.187-46.7884-119.3299-98.3869QC'd by NCI Chemotherapeutic Agents Repository
Inhibitor15.744190.090881Complete curve; high efficacy-4.80291.66040.9839-89.14830.9425-1.10 0 0 0 0 0 0 0 0 0 0-83.94382.9677.20542.7371-0.61222.788-2.9535-4.3083-13.5377-29.9354-76.8118-83.9438QC'd by SigmaAldrich
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC167MR
Protocol: Tox21 Assay Protocol Summary:

5 uL of culture medium (DMEM containing 10% FBS) per well was dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). After 23 nL compound or DMSO vehicle was transferred into assay plate by a pintool work station (Kalypsys, San Diego, CA), fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive040.06820.17150.15520.2805-0.08310.0682QC'd by "APAC"0
Inactive040.0073-0.03930.005-0.09740.03070.0073QC'd by "APAC"0
Inactive04-0.4123-0.248-0.1541-0.1037-0.0973-0.4123QC'd by "APAC"0
Inactive040.19330.41050.28830.44640.38910.1933QC'd by "APAC"0
Inactive040.44160.65360.7260.63220.73960.4416QC'd by "APAC"0
Inactive040.2127-0.00470.08240.2587-0.01090.2127QC'd by "APAC"0
Inactive040.13480.40170.15030.02750.21030.1348QC'd by "APAC"0
Inactive040.16380.07840.19640.35280.10370.1638QC'd by "APAC"0
Inactive04-0.0775-0.1328-0.144-0.2205-0.105-0.0775QC'd by "APAC"0
Inactive040.12810.06390.0321-0.01010.04060.1281QC'd by "APAC"0
Inactive04-0.4235-0.3306-0.3534-0.2876-0.4525-0.4235QC'd by "APAC"0
Inactive040.1880.24950.21320.11330.30530.188QC'd by "APAC"0
Inactive040.26490.13370.33710.1823-0.01240.2649QC'd by "APAC"0
Inactive040.14720.44310.35470.41120.45620.1472QC'd by "APAC"0
Inactive040.18370.1140.0230.16450.38450.1837QC'd by "APAC"0
Inactive04-0.5082-0.4883-0.5711-0.5038-0.4992-0.5082QC'd by "APAC"0
Inactive04-0.2494-0.1585-0.0187-0.265-0.2494-0.2494QC'd by "APAC"0
Inactive04-0.489-0.6545-0.2063-0.2875-0.5573-0.489QC'd by "APAC"0
Inactive04-0.1512-0.1725-0.2697-0.1595-0.2932-0.1512QC'd by "APAC"0
Inactive040.1730.29550.30070.26150.34070.173QC'd by "APAC"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Neuropeptide Y receptor type 1
External ID: CHEMBL5291834
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL4777
ChEMBL Target Name: Neuropeptide Y receptor type 1
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac1-activator-v
Protocol: Briefly, three uL of reagents (100 nM EPAC1, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control of 6.5 mM cAMP.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = 1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 || ratio.curve_class == 2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds also have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.00123 uMActivity at 0.00610 uMActivity at 0.00630 uMActivity at 0.013 uMActivity at 0.025 uMActivity at 0.042 uMActivity at 0.068 uMActivity at 0.120 uMActivity at 0.202 uMActivity at 0.314 uMActivity at 0.611 uMActivity at 1.089 uMActivity at 1.568 uMActivity at 3.058 uMActivity at 5.503 uMActivity at 7.834 uMActivity at 15.29 uMActivity at 27.41 uMActivity at 39.61 uMActivity at 75.76 uMActivity at 149.6 uMActivity at 201.4 uMActivity at 319.7 uMActivity at 605.8 uMActivity at 817.0 uMCompound QC
Activator112.20182659.1944100Partial curve; high efficacy-3.954.50450.99882689.2430.04562.10 0 0 0 0 02175.7605-2.186418.44120.797383.3849426.79582175.7605QC'd by Microsource
Activator0.1778128.312895Complete curve; high efficacy-6.754.95490.9927134.48516.17231.10 0 0 0 0 114.5095.603324.7938142.7655131.831127.775314.509QC'd by SigmaAldrich
Activator0.4467126.107791Complete curve; high efficacy-6.351.86170.9998123.6363-2.47141.10 0 0 0 0 10.2688-2.58447.816180.257120.2764123.38950.2688QC'd by SigmaAldrich
Activator1.122117.125490Complete curve; high efficacy-5.952.24810.9788132.426515.30111.10 0 0 0 0143.318715.809439.5652122.9227119.7824143.3187QC'd by Tocris
Activator112.20181122.177671Partial curve; high efficacy-3.954.50450.99831140.568818.39122.10 0 0 0 0922.79033.23057.588941.6506204.8302922.7903QC'd by Timtec
Activator100709.567358Partial curve; high efficacy-43.990.9988700.7079-8.85942.10 0 0 0 0 0592.8155-15.9019-8.65324.5286-20.153176.4838592.8155QC'd by CarsonNewman-SPECS
Activator79.4328826.407657Partial curve; high efficacy-4.14.0950.9972826.76670.35912.10 0 0 0 0 0665.6736-2.5729-3.4508-16.761725.5851154.5978665.6736QC'd by Prestwick Chemical; Inc.
Activator100589.932555Partial curve; high efficacy-43.24750.984613.297923.36542.10 0 0 0 0 0498.6162-5.7471.05937.654362.5313194.9599498.6162QC'd by CarsonNewman-SPECS
Activator112.2018558.656655Partial curve; high efficacy-3.954.50450.9992557.2619-1.39472.10 0 0 0 0448.681-6.8565-3.87677.063281.1858448.681QC'd by Vitas
Activator100612.475355Partial curve; high efficacy-44.50450.9972611.2868-1.18852.10 0 0 0 0 0533.4091-10.048-5.6002-8.206821.4265142.7223533.4091QC'd by Pharmacopeia
Activator100511.551853Partial curve; high efficacy-44.44950.9965517.54675.9952.10 0 0 0 0 0453.9884-10.486710.44483.974421.1983121.4017453.9884QC'd by CarsonNewman-SPECS
Activator112.2018440.198152Partial curve; high efficacy-3.954.0950.9989439.2753-0.92282.10 0 0 0 0348.6312-5.1918-3.30186.970574.6909348.6312QC'd by Sequoia
Activator100497.63552Partial curve; high efficacy-43.67720.9977486.8252-10.80982.10 0 0 0 0 0401.671-14.9427-21.3461-13.18642.6858130.5049401.671QC'd by Pharmacopeia
Activator100438.508551Partial curve; high efficacy-44.95490.9987437.7956-0.71282.10 0 0 0 0 0392.29-7.25310.2913-4.1769.366693.145392.29QC'd by Pharmacopeia
Activator56.2341819.971850Partial curve; high efficacy-4.253.24750.9993802.9227-17.0492.10 0 0 0 0787.1792-7.4836-10.9833-14.2075580.1833787.1792QC'd by NCI
Activator112.2018363.64150Partial curve; high efficacy-3.954.95490.9972355.9752-7.66582.10 0 0 0 0 0293.7089-16.73630.4741-6.1211-4.368934.2599293.7089QC'd by Pharmacopeia
Activator112.2018363.029750Partial curve; high efficacy-3.954.50450.9992370.42997.40022.10 0 0 0 0 0299.70063.69434.700413.02825.857563.7543299.7006QC'd by Pharmacopeia
Activator100295.813448Partial curve; high efficacy-43.62720.9992302.03896.22552.10 0 0 0 0 0251.69912.67988.48118.67789.650486.3825251.6991QC'd by CarsonNewman-SPECS
Activator100233.346946Partial curve; high efficacy-44.50450.9961221.7227-11.62422.10 0 0 0 0 0192.4676-6.6471-16.5394-18.4762-5.603142.3638192.4676QC'd by CarsonNewman-SPECS
Activator112.2018234.606146Partial curve; high efficacy-3.954.95490.984235.23560.62952.10 0 0 0 0 0197.01480.9163-4.51361.948217.44218.7867197.0148QC'd by Pharmacopeia
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC167CG
Protocol: Tox21 Assay Protocol Summary:

2,000 HEK293 cells in 5 uL of culture medium containing 10% dialyzed FBS per well were dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (Thermo Scientific). The assay plates were incubated for 4-5 hr at 37C to allow cell attachment to the well bottom, followed by the transfer of 23 nL compound or DMSO vehicle by a pintool work station (Kalypsys, San Diego, CA). After the assay plates were incubated overnight at 37C and 5% CO2, fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.0303-0.04260.0285-0.09190.0085-0.0303QC'd by "NCI"0
Inactive040.0853-0.06580.02019.0E-40.06280.0853QC'd by "NCI"0
Inactive040.16730.04180.01560.0204-0.00980.1673QC'd by "NCI"0
Inactive04-0.1980.02190.0160.02350.0689-0.198QC'd by "SigmaAldrich"0
Inactive040.0038-0.0014-0.00825.0E-4-0.1170.0038QC'd by "NCI"0
Inactive040.0026-0.0041-0.01760.0697-0.01480.0026QC'd by "NCI"0
Inactive040.1333-0.0845-0.0206-0.01310.12030.1333QC'd by "NCI"0
Inactive040.03690.00440.0618-0.01070.01570.0369QC'd by "NCI"0
Inactive04-0.02150.02550.01530.1030.0492-0.0215QC'd by "NCI"0
Inactive04-0.00280.08780.0034-0.01623.0E-4-0.0028QC'd by "Labotest"0
Inactive040.02210.0083-0.0285-0.04060.10790.0221QC'd by "NCI"0
Inactive040.02430.10020.08470.0514-0.00220.0243QC'd by "NCI"0
Inactive040.00680.024-0.00130.0328-0.11050.0068QC'd by "NCI"0
Inactive040.03090.0251-0.2255-0.1044-0.07930.0309QC'd by "NCI"0
Inactive04-0.0428-0.0779-0.07410.0110.0229-0.0428QC'd by "NCI"0
Inactive040.07660.0357-0.02130.0861-0.01260.0766QC'd by "NCI"0
Inactive04-0.0349-0.0548-0.0746-0.0452-0.1742-0.0349QC'd by "NCI"0
Inactive040.15650.01040.0178-0.0320.02410.1565QC'd by "Chembridge"0
Inactive04-0.05070.0691-0.01840.01950.0897-0.0507QC'd by "NCI"0
Inactive04-0.0232-0.1816-0.1161-0.2126-0.2187-0.0232QC'd by "NCI"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Motilin receptor
External ID: CHEMBL5291833
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL2203
ChEMBL Target Name: Motilin receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
9.4393AC50=9439.3nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac1-inhibitor-v
Protocol: Briefly, three uL of reagents (100 nM EPAC1, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control ATA and DMSO.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = -1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 || ratio.curve_class == -2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.00123 uMActivity at 0.00610 uMActivity at 0.00630 uMActivity at 0.013 uMActivity at 0.025 uMActivity at 0.042 uMActivity at 0.068 uMActivity at 0.120 uMActivity at 0.202 uMActivity at 0.314 uMActivity at 0.611 uMActivity at 1.089 uMActivity at 1.568 uMActivity at 3.058 uMActivity at 5.503 uMActivity at 7.834 uMActivity at 15.29 uMActivity at 27.41 uMActivity at 39.61 uMActivity at 75.76 uMActivity at 149.6 uMActivity at 201.4 uMActivity at 319.7 uMActivity at 605.8 uMActivity at 817.0 uMCompound QC
Inactive04.95490.78241.505912.540 0 0 0 0 02.50148.657916.73337.679-0.41183.23982.5014QC'd by Pharmacopeia
Inactive04.95490.5059222.540 0 0 0 0 06.253623.167131.574120.397112.323123.69316.2536QC'd by Pharmacopeia
Inactive03.06540.487561440 0 0 0 0 07.117813.853713.063510.239619.91049.84967.1178QC'd by Pharmacopeia
Inactive04.95490.8513-6.122214.540 0 0 0 0 0-2.601918.618115.697111.958910.649712.3116-2.6019QC'd by Pharmacopeia
Inactive04.95490.4441-8.935340 0 0 0 0 04.128-6.61282.85915.135-4.2457-1.68664.128QC'd by Pharmacopeia
Inactive00.90.60781.5740 0 0 0 0 03.28024.93557.52122.24671.45360.76263.2802QC'd by Pharmacopeia
Inactive0415.807823.846715.21025.400717.117711.703815.8078QC'd by Pharmacopeia
Inactive04-4.32494.35640.9262-8.26096.61363.2318-4.3249QC'd by Pharmacopeia
Inactive04.95490.3866.51640 0 0 0 0 118.561314.469622.616710.242516.25858.074118.5613QC'd by Pharmacopeia
Inactive04.95490.793515-5.385140 0 0 0 0 016.1015-1.154320.964112.456114.239511.422716.1015QC'd by Pharmacopeia
Inactive04.50450.947310.52240 0 0 0 0 08.684621.396522.306312.781710.406512.7248.6846QC'd by Pharmacopeia
Inactive00.90.72282.68042640 0 0 0 0 0-2.766319.58196.42455.7298.03594.8741-2.7663QC'd by Pharmacopeia
Inactive04.44950.86116.58.540 0 0 0 0 19.3158.510610.85386.227115.368416.53989.315QC'd by Pharmacopeia
Inactive04.95490.574110.50.708340 0 0 0 0 012.21914.1249-2.326514.46343.839910.786612.2191QC'd by Pharmacopeia
Inactive049.708413.42218.37480.333810.101818.04579.7084QC'd by Pharmacopeia
Inactive04.95490.4502-7.41418.540 0 0 0 0 0-4.51189.055914.9898-2.014610.28748.4395-4.5118QC'd by Pharmacopeia
Inactive04.95490.6758280.244340 0 0 0 0 023.04957.0826-6.46314.13492.386-6.030223.0495QC'd by Pharmacopeia
Inactive04.44950.7608-2.59256.540 0 0 0 0 18.96953.44595.67689.8855-0.0456-2.16048.9695QC'd by Pharmacopeia
Inactive02.63840.66513.52040 0 0 0 0 013.574216.035922.509821.272319.386214.340813.5742QC'd by Pharmacopeia
Inactive04-3.2632-16.2622-13.7616-11.6684-9.5243-17.6211-3.2632QC'd by Prestwick Chemical; Inc.
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC167MB
Protocol: Tox21 Assay Protocol Summary:

5 uL of culture medium (DMEM containing 10% FBS) per well was dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). After 23 nL compound or DMSO vehicle was transferred into assay plate by a pintool work station (Kalypsys, San Diego, CA), fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.060.0769-0.0561-0.05340.0765-0.06QC'd by "NCI"0
Inactive04-0.02860.01850.15430.03970.0134-0.0286QC'd by "NCI"0
Inactive041.25510.11730.01450.07070.51551.2551QC'd by "NCI"0
Inactive040.0380.0229-0.1395-0.01880.42040.038QC'd by "SigmaAldrich"0
Inactive041.3250.07660.1836-0.10240.07711.325QC'd by "NCI"0
Inactive040.1088-0.12430.0941-0.0246-0.04550.1088QC'd by "NCI"0
Inactive040.00260.0529-0.1116-0.1678-0.11720.0026QC'd by "NCI"0
Inactive040.17340.0511-0.06420.11-0.13760.1734QC'd by "NCI"0
Inactive040.0031-0.0257-0.0731-0.021-0.01490.0031QC'd by "NCI"0
Inactive04.0950.98722.5040 0 0 0 02.51080.00570.26280.01340.77542.5108QC'd by "Labotest"0
Inactive04-0.05950.0115-0.03130.04540.0652-0.0595QC'd by "NCI"0
Inactive040.7551-0.0030.0690.14220.06940.7551QC'd by "NCI"0
Inactive04-0.0762-0.099-0.14750.0756-0.1338-0.0762QC'd by "NCI"0
Inactive040.0533-0.1182-0.00850.0808-0.08810.0533QC'd by "NCI"0
Inactive041.4117-0.0519-0.0295-0.05670.23241.4117QC'd by "NCI"0
Inactive040.15250.02280.10290.03280.11910.1525QC'd by "NCI"0
Inactive040.97520.1286-0.0289-0.0041-0.01590.9752QC'd by "NCI"0
Inactive040.090.11160.0522-0.0224-0.17680.09QC'd by "Chembridge"0
Inactive040.12760.09120.04220.0790.08710.1276QC'd by "NCI"0
Inactive04-0.05040.00170.0374-0.2014-0.0226-0.0504QC'd by "NCI"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Voltage-gated inwardly rectifying potassium channel KCNH2
External ID: CHEMBL5291828
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL240
ChEMBL Target Name: HERG
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
350.002AC50=350001.6nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")Outside typical range
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
4.06AC50=4060nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
9.1AC50=9100nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac2-inhibitor-f1f2f3f4
Protocol: Briefly, three uL of reagents (100 nM EPAC2, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control ATA and DMSO.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = -1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 || ratio.curve_class == -2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0006615435 uMActivity at 0.0009894114 uMActivity at 0.00193 uMActivity at 0.00314 uMActivity at 0.00579 uMActivity at 0.00818 uMActivity at 0.017 uMActivity at 0.024 uMActivity at 0.052 uMActivity at 0.068 uMActivity at 0.110 uMActivity at 0.158 uMActivity at 0.332 uMActivity at 0.473 uMActivity at 0.944 uMActivity at 1.419 uMActivity at 2.593 uMActivity at 4.249 uMActivity at 7.775 uMActivity at 12.71 uMActivity at 21.91 uMActivity at 38.14 uMActivity at 62.54 uMActivity at 114.2 uMActivity at 201.6 uMActivity at 233.1 uMCompound QC
Inhibitor6.74561494.3646100Complete curve; high efficacy-5.1712.63840.965-1503.2555-8.8908-1.10 0 0 0 0 0 0 0-1260.1318-11.1547-6.7992-1.606913.7817-128.8233-1191.5094-1764.3843-1260.1318QC'd by Enamine
Inhibitor0.09531682.33392Complete curve; high efficacy-7.0211.47870.9805-97.06811585.265-1.11 0 0 0 0 0 0 0-38.69643173.90851467.8379734.024261.6921-105.8029-252.970921.2579-38.6964QC'd by Richard A Houghten - Torrey Pines Institute for Molecular Studies - MLI PSL
Inhibitor0.9528462.085591Complete curve; high efficacy-6.0214.95490.8781-147.1919314.8936-1.11 0 1 0 0 0 0 0-170.5569526.5921229.1516847.3074389.4244-222.0195-22.4759-166.4298-170.5569QC'd by Chem Div
Inhibitor0.067524.59186Complete curve; high efficacy-7.1713.19250.4734-42.2643-66.8553-1.10 0 0 0 0 0 0 1-61.4189-67.8557-65.4209-48.882-33.4136-32.3036-35.0315-67.9216-61.4189QC'd by Scott E Schaus - Boston Univ. - MLI CMLD
Inhibitor0.01921.607386Complete curve; high efficacy-7.7213.06540.8497-38.71-60.3172-1.10 0 0 0 0 0-33.8968-60.016-50.4881-38.7102-36.9245-45.4763-33.8968QC'd by Specs
Inhibitor5.548138.182186Complete curve; high efficacy-5.25591.37230.995-149.829-11.6469-1.10 0 0 0 0 0 0 0 0 0 0-146.0322-15.3641-14.426-10.6845-2.5307-13.6678-14.3878-34.5896-65.4595-119.9073-140.2727-146.0322QC'd by Tocris
Inhibitor1.19956.031886Complete curve; high efficacy-5.9214.95490.4811-77.4305-71.3987-1.10 0 0 0 0 0 0 1-69.1964-75.7075-69.7865-73.9043-66.5822-78.692-74.9799-77.8985-69.1964QC'd by NIH Chemical Genomics Center (NCGC)
Inhibitor3.013174.519685Complete curve; high efficacy-5.5211.24750.976-90.5995-16.08-1.10 0 0 0 0 0 0 0-88.471-25.2771-12.4556-14.1585-17.913-51.4226-73.9001-93.7883-88.471QC'd by Key Organics Ltd.
Inhibitor1.694472.743985Complete curve; high efficacy-5.7711.62660.9736-86.1149-13.3709-1.10 0 0 0 0 0 0 0-90.2672-16.7468-16.0693-11.6766-14.4415-64.3096-72.7308-87.9452-90.2672QC'd by Asinex Ltd.
Inhibitor0.151140.645685Complete curve; high efficacy-6.8210.90.9849-44.2164-184.862-1.10 0 0 0 0 0-53.3465-180.1774-166.0242-127.2248-89.878-43.6723-53.3465QC'd by Sytravon
Inhibitor2.478271.919785Complete curve; high efficacy-5.60591.210.9515-90.347-18.4273-1.10 0 0 0 0 0 0 0 0 0 0-92.3794-29.4176-25.4576-10.6267-18.3361-13.1226-18.0422-51.5862-63.4387-81.7748-84.6589-92.3794QC'd by Microsource
Inhibitor2.685576.254185Complete curve; high efficacy-5.5711.50950.9645-93.4891-17.235-1.10 0 0 0 0 0 0 0-83.3595-19.1979-15.5958-20.1946-17.5552-53.8059-81.8551-105.9967-83.3595QC'd by Specs
Inhibitor3.013193.599885Complete curve; high efficacy-5.5214.0950.9841-106.6274-13.0276-1.10 0 0 0 0 0 0 0-100.9847-15.8586-12.6799-7.6231-13.2588-38.4269-100.335-118.4749-100.9847QC'd by Chem Div
Inhibitor2.208770.786885Complete curve; high efficacy-5.65591.46410.9882-83.9058-13.119-1.10 0 0 0 0 0 0 0 0 0 0-80.3383-14.6034-13.7105-8.1697-17.0327-13.9823-20.0222-32.5347-69.34-76.772-86.3228-80.3383QC'd by Prestwick Chemical; Inc.
Inhibitor16.9441355.352885Complete curve; high efficacy-4.7711.10.9993-356.9435-1.5907-1.10 0 0 0 0 0 0 0-318.1315-3.9948-2.9251-4.53120-40.0216-141.0144-284.0357-318.1315QC'd by Enamine
Inhibitor5.358275.688784Complete curve; high efficacy-5.2711.10.986-94.241-18.5523-1.10 0 0 0 0 0 0 0-92.9398-25.1237-17.5814-17.053-18.0751-44.0369-68.5795-88.598-92.9398QC'd by Jeff Aube - Univ. of Kansas - MLI CMLD
Inhibitor0.7569135.583784Complete curve; high efficacy-6.1211.34370.7835-54.498981.0848-1.11 0 0 0 1 0 0 00114.033182.571172.543333.2174-170.3018-49.8526-108.21670QC'd by Sergey Kozmin - Univ. of Chicago - MLI CMLD
Inhibitor4.775597.071984Complete curve; high efficacy-5.3210.80.9918-103.7002-6.6283-1.10 0 0 0 0 0 0 0-94.1135-1.4836-13.9984-10.0011-18.7058-41.6061-71.5982-94.9636-94.1135QC'd by Key Organics Ltd.
Inhibitor3.793376.191984Complete curve; high efficacy-5.4211.10.9724-84.3357-8.1438-1.10 0 0 0 0 0 0 0-80.18290.3249-17.896-10.6249-19.5352-32.7938-69.8932-81.1131-80.1829QC'd by ChemBridge
Inhibitor3.013169.492584Complete curve; high efficacy-5.5211.55790.9812-74.2039-4.7114-1.10 0 0 0 0 0 0 0-65.987-5.0213-5.2016-3.1865-8.3924-32.9126-65.2042-82.0627-65.987QC'd by Asinex Ltd.
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC478MG
Protocol: Tox21 Assay Protocol Summary:

5 uL of culture medium (MEM containing 10% FBS) per well was dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). After 23 nL compound or DMSO vehicle was transferred into assay plate by a pintool work station (Kalypsys, San Diego, CA), fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.0468-1.0E-4-0.0634-0.0128-0.1309-0.0468QC'd by "NCI"0
Inactive04-0.02170.0466-0.04120.00330.0551-0.0217QC'd by "NCI"0
Inactive04-0.0248-0.00450.0622-0.03730.0284-0.0248QC'd by "NCI"0
Inactive040.01860.0540.055-7.0E-40.08120.0186QC'd by "SigmaAldrich"0
Inactive040.02420.07270.1578-0.01480.02860.0242QC'd by "NCI"0
Inactive040.08870.03620.13790.04160.03120.0887QC'd by "NCI"0
Inactive040.10310.0424-0.0028-0.06470.0120.1031QC'd by "NCI"0
Inactive040.022-0.01990.0104-0.01420.03070.022QC'd by "NCI"0
Inactive040.58190.1190.05910.03290.05860.5819QC'd by "NCI"0
Inactive04-0.01230.04580.0457-0.03880.0399-0.0123QC'd by "Labotest"0
Inactive04-0.0094-0.02560.0289-0.00760-0.0094QC'd by "NCI"0
Inactive040.11950.07450.00670.004-0.05970.1195QC'd by "NCI"0
Inactive04-0.0059-0.05640.01470.0049-0.0156-0.0059QC'd by "NCI"0
Inactive04-0.05470.0295-0.0247-0.0665-0.0356-0.0547QC'd by "NCI"0
Inactive04-0.0413-0.0059-0.1195-0.0027-0.0175-0.0413QC'd by "NCI"0
Inactive040.175-0.00450.11290.06590.06270.175QC'd by "NCI"0
Inactive04-0.0317-0.0316-0.01050.0141-0.0074-0.0317QC'd by "NCI"0
Inactive040.06210.0243-0.0520.16910.01120.0621QC'd by "Chembridge"0
Inactive040.0158-0.02480.0493-0.0242-0.02880.0158QC'd by "NCI"0
Inactive04-0.0654-0.1331-0.0734-0.03930.0109-0.0654QC'd by "NCI"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac2-activator-f1f2f3f4
Protocol: Briefly, three uL of reagents (100 nM EPAC2, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control of 6.5 mM cAMP.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = 1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 || ratio.curve_class == 2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds also have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0008905393 uMActivity at 0.00133 uMActivity at 0.00260 uMActivity at 0.00423 uMActivity at 0.00779 uMActivity at 0.011 uMActivity at 0.023 uMActivity at 0.033 uMActivity at 0.070 uMActivity at 0.092 uMActivity at 0.148 uMActivity at 0.213 uMActivity at 0.447 uMActivity at 0.637 uMActivity at 1.271 uMActivity at 1.910 uMActivity at 3.487 uMActivity at 5.719 uMActivity at 10.47 uMActivity at 17.11 uMActivity at 29.50 uMActivity at 51.33 uMActivity at 83.79 uMActivity at 153.7 uMActivity at 271.3 uMActivity at 313.8 uMCompound QC
Activator112.20187915.679100Partial curve; partial efficacy-3.954.95490.9747782.4016-133.27742.20 0 0 0 0 0 0 06550.84315.03831.4327-1.8529-0.749-1.2828-0.8048-0.22086550.8431QC'd by Asinex Ltd.
Activator112.201819185.7415100Partial curve; partial efficacy-3.954.95490.974118856.4676-329.27382.20 0 0 0 0 0 0 015872.4475-8.7565-6.44080.7001-5.8905-4.8567-9.6925-5.186515872.4475QC'd by UrkORgSynthesis Ltd
Activator112.20182376.3081100Partial curve; partial efficacy-3.954.50450.96332450.525774.21752.20 0 0 0 0 0 0 01992.2973-3.5317-4.719354.518428.631718.0366392.2696419.74541992.2973QC'd by ChemBridge
Activator1005725.9134100Partial curve; partial efficacy-44.0450.99545798.94273.02862.20 0 0 0 0 0 0 04931.07310.88030.5649-0.79113.818542.4751348.67511565.75484931.0731QC'd by NCI Chemotherapeutic Agents Repository
Activator15.8489881.223293Complete curve; high efficacy-4.82.25260.9634878.8998-2.32341.10 0 0 0 0 0 0 0728.8831-4.2226-4.7068-6.1137-1.092920.5614426.6125996.485728.8831QC'd by Asinex Ltd.
Activator1001997.138290Partial curve; high efficacy-44.0450.99832014.320917.18262.10 0 0 0 0 0 0 01721.64183.45253.3783.98239.347632.206571.663507.92931721.6418QC'd by Asinex Ltd.
Activator7.9433108.365383Complete curve; high efficacy-5.11.210.9975113.12734.7621.10 0 0 0 0 0 0 0108.98595.39883.16413.682813.914628.618979.4348108.9185108.9859QC'd by Sigma Chemical Company
Activator25.118997.527781Complete curve; high efficacy-4.61.96730.9962100.57073.0431.10 0 0 0 0 0 0 095.23746.18913.79460.66732.34614.271527.873494.956595.2374QC'd by InterBioScreen
Activator25.063866.323780Complete curve; high efficacy-4.6011.96730.971468.90312.57941.10 0 0 0 0 0 0 0 0 0 062.28613.0694-0.84460.65480.83983.1961.3298.84319.809419.514263.225762.2861QC'd by Labotest
Activator31.6228320.503480Complete curve; high efficacy-4.53.19250.9981307.6914-12.8121.10 0 0 0 0 0 0 0307.0772-15.3847-10.2656-16.2349-18.82421.575514.2479288.2493307.0772QC'd by Asinex Ltd.
Activator1001250.315172Partial curve; high efficacy-43.29750.98911276.083525.76852.10 0 0 0 0 0 0 01037.46636.76246.94936.72769.584724.545121.6531390.61691037.4663QC'd by Enamine
Activator112.20181092.625571Partial curve; high efficacy-3.954.95490.99661125.057332.43182.10 0 0 0 0 0 0 0942.259160.508746.391241.266336.193223.219115.6355148.326942.2591QC'd by Chem Div
Activator112.20181105.299770Partial curve; high efficacy-3.954.50450.99981105.0358-0.26392.10 0 0 0 0 0 0 0894.04191.4284-3.389-3.9616-0.18640.77246.7469165.5024894.0419QC'd by Chem Div
Activator1001065.59368Partial curve; high efficacy-42.95230.95151111.000645.40762.10 0 0 0 0 0 0 0881.7465-2.6974-2.14370.95036.938571.8385203.0705370.0237881.7465QC'd by ChemBridge
Activator100908.159763Partial curve; high efficacy-42.30310.984930.232822.07312.10 0 0 0 0 0 0 0707.9397-2.3217-0.4363-1.2562.350233.6888101.7463350.2479707.9397QC'd by InterBioScreen
Activator112.2018806.059962Partial curve; high efficacy-3.954.95490.9966816.201610.14172.10 0 0 0 0 0 0 0676.7841.27153.39650.67385.39157.092142.5928122.1389676.784QC'd by NCI Chemotherapeutic Agents Repository
Activator112.2018783.792462Partial curve; high efficacy-3.954.95490.9997789.93116.13872.10 0 0 0 0 0 0 0655.00097.20577.65892.2588-0.34564.789911.3778112.2218655.0009QC'd by Maybridge
Activator100816.162161Partial curve; high efficacy-43.24750.987832.455416.29332.10 0 0 0 0 0 0 0673.5076-6.24851.84670.25863.852314.682781.096254.4096673.5076QC'd by TimTec
Activator100704.591758Partial curve; high efficacy-43.24750.9989709.34234.75062.10 0 0 0 0 0 0 0571.12910.7768-0.8073-0.51952.84717.869421.5244216.3485571.1291QC'd by Chem Div
Activator100588.690455Partial curve; high efficacy-44.95490.9978589.48410.79372.10 0 0 0 0 0 0 0528.2116-8.0271-8.2801-5.8459-1.28170.261218.8362129.6249528.2116QC'd by Specs
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC478CB
Protocol: Tox21 Assay Protocol Summary:

2,000 HepG2 cells in 5 uL of culture medium (MEM containing 10% FBS) per well were dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). The assay plates were incubated overnight at 37 C to allow cell attachment to the well bottom, followed by the transfer of 23 nL compound or DMSO vehicle by a pintool work station (Kalypsys , San Diego, CA). After the assay plates were incubated for 1 hr at 37 C and 5% CO2, fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590 nm respectively.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive040.2003-0.01150.00710.23730.09540.2003QC'd by "NCI"0
Inactive040.1113-0.03910.08984.0E-4-0.03890.1113QC'd by "NCI"0
Inactive04-0.09730.0277-0.0084-0.00980.0055-0.0973QC'd by "NCI"0
Inactive04-0.1827-0.0289-0.0224-0.1537-0.0181-0.1827QC'd by "SigmaAldrich"0
Inactive040.5452-0.03350.0032-0.01370.01630.5452QC'd by "NCI"0
Inactive04-0.05130.011-0.0106-0.0503-0.0065-0.0513QC'd by "NCI"0
Inactive04-0.0252-0.1196-0.0502-0.05650.0376-0.0252QC'd by "NCI"0
Inactive040.10450.0373-0.01590.03940.00210.1045QC'd by "NCI"0
Inactive04-0.24220.0063-0.0071-0.0119-0.0133-0.2422QC'd by "NCI"0
Inactive04.50450.98673040 0 0 0 03.1340.15520.13580.19860.6053.134QC'd by "Labotest"0
Inactive04-0.0090.01850.03930.2310.0436-0.009QC'd by "NCI"0
Inactive040.07510.02710.22620.17550.01740.0751QC'd by "NCI"0
Inactive040.0132-0.0598-0.0350.09430.07230.0132QC'd by "NCI"0
Inactive049.0E-4-0.0911-0.05740.15930.17099.0E-4QC'd by "NCI"0
Inactive040.6834-0.1194-0.00280.3720.19860.6834QC'd by "NCI"0
Inactive040.1104-0.08290.06180.16230.0230.1104QC'd by "NCI"0
Inactive040.5456-0.0786-0.0186-0.0058-0.00230.5456QC'd by "NCI"0
Inactive04-0.1424-0.0976-0.10020.027-0.1146-0.1424QC'd by "Chembridge"0
Inactive040.0252-0.0593-0.08240.12910.04990.0252QC'd by "NCI"0
Inactive040.0384-0.2038-0.1551-0.007-0.01920.0384QC'd by "NCI"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac2-activator-v2
Protocol: Briefly, three uL of reagents (100 nM EPAC2, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control of 6.5 mM cAMP.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = 1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == 1.2 || ratio.curve_class == 2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds also have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.00123 uMActivity at 0.00246 uMActivity at 0.00610 uMActivity at 0.00630 uMActivity at 0.011 uMActivity at 0.025 uMActivity at 0.045 uMActivity at 0.067 uMActivity at 0.120 uMActivity at 0.202 uMActivity at 0.314 uMActivity at 0.611 uMActivity at 1.089 uMActivity at 1.568 uMActivity at 3.058 uMActivity at 5.503 uMActivity at 7.834 uMActivity at 15.29 uMActivity at 27.41 uMActivity at 39.61 uMActivity at 75.76 uMActivity at 149.6 uMActivity at 201.4 uMActivity at 319.7 uMActivity at 605.8 uMActivity at 817.0 uMCompound QC
Inactive04.95490.8563-9.9979-3.18240 0 0 0 0 0-8.823-2.9167-5.5515-1.8183-11.2482-10.2408-8.823QC'd by Microsource
Inactive01.53860.5644-4.854640 0 0 0 0 1-7.5471-0.6835-9.0455-3.7039-1.19033.153-7.5471QC'd by Microsource
Inactive04.95490.431-21.09492.199340 0 0 0 0 0-29.6624-1.0839-27.7771-29.2982-9.5254-9.846-29.6624QC'd by Microsource
Inactive04.95490.3341-1.3603-6.912440 0 0 0 0 1-15.5699-9.927-2.5767-5.8552-8.5221-2.3836-15.5699QC'd by Microsource
Inhibitor0.891314.13510Complete curve; partial efficacy; poor fit-6.052.12110.6534-22.6728-8.5377-1.40 0 0 0 0 0-21.1521-8.7814-12.9514-21.2535-30.9774-17.0722-21.1521QC'd by Microsource
Inactive03.1320.47250.5-4.228440 0 0 0 0 0-0.2612-1.9763-2.0592-8.107-2.12880.8201-0.2612QC'd by Microsource
Inactive04.95490.4917-10.967-2.314940 0 0 0 0 0-10.1405-1.5124-2.5506-5.4129-17.8892-4.0897-10.1405QC'd by Microsource
Inactive03.990.5924-19.9348040 0 0 0 0 0-28.6957-6.23025.7918-15.0449-23.6413-7.309-28.6957QC'd by Microsource
Inactive04.95490.4102-6.1308540 0 0 0 0 0-4.3550.82898.6021-2.8349-16.3592.161-4.355QC'd by Microsource
Inactive04.95490.369-1.5-14.336940 0 0 0 0 1-9.3021-12.78082.0015-0.2528-12.58754.4401-9.3021QC'd by Microsource
Inhibitor0.707923.62210Complete curve; partial efficacy; poor fit-6.153.06540.6513-24.5288-0.9067-1.40 0 0 0 0 1-13.9864-1.5889-9.6741-27.4469-33.3677-12.1786-13.9864QC'd by Microsource
Inactive04-22.4775-11.6889-11.6628-13.5576-20.9035-8.6191-22.4775QC'd by Microsource
Inactive00.80.7088-25.4933-11.691840 0 0 0 0 0-24.5778-16.5266-8.0765-17.2318-20.0221-22.1348-24.5778QC'd by Microsource
Inhibitor0.177819.99850Complete curve; partial efficacy; poor fit-6.754.95490.6578-21.9347-1.9361-1.40 0 0 0 0 0-23.6561-4.5301-30.7789-20.7284-19.2667-15.4849-23.6561QC'd by Microsource
Inactive010.9184-24.9585-2.733140 0 0 0 0 1-15.8401-9.7776-20.4013-20.4952-26.2154-25.1202-15.8401QC'd by Microsource
Inactive04-16.8662-15.0798-16.9114-17.163-13.1564-16.5558-16.8662QC'd by Microsource
Inactive047.75753.31266.13836.2047-2.02096.22127.7575QC'd by Microsource
Inactive043.75979.79097.02243.0975-6.896512.31463.7597QC'd by Microsource
Inactive04.95490.6335-4.9129640 0 0 0 0 0-8.84676.11915.34965.0731-9.09412.984-8.8467QC'd by Microsource
Inactive04.95490.7097-7.2734040 0 0 0 0 0-5.9151.1538-1.05870.2688-11.4778-4.1213-5.915QC'd by Microsource
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC478MR
Protocol: Tox21 Assay Protocol Summary:

5 uL of culture medium (MEM containing 10% FBS) per well was dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). After 23 nL compound or DMSO vehicle was transferred into assay plate by a pintool work station (Kalypsys, San Diego, CA), fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.12420.2628-0.1782-0.4447-0.2156-0.1242QC'd by "NCI"0
Inactive040.52820.2696-0.353-0.2319-0.17610.5282QC'd by "NCI"0
Inactive040.36990.109-0.00360.2172-0.0050.3699QC'd by "NCI"0
Inactive040.003-0.1398-0.2166-0.05930.03410.003QC'd by "SigmaAldrich"0
Inactive040.0037-0.18840.15210.18170.12320.0037QC'd by "NCI"0
Inactive040.42260.0606-0.0267-0.1598-0.03750.4226QC'd by "NCI"0
Inactive04-0.1083-0.0289-0.054-0.2945-0.072-0.1083QC'd by "NCI"0
Inactive04-0.0618-0.03660.04-0.2576-0.1156-0.0618QC'd by "NCI"0
Inactive040.0450.2884-0.027-0.166-0.30740.045QC'd by "NCI"0
Inactive04-0.2251-0.37-0.4364-0.0983-0.1209-0.2251QC'd by "Labotest"0
Inactive04-0.32420.23140.0134-0.2318-0.0596-0.3242QC'd by "NCI"0
Inactive04-0.01610.01530.03390.01490.0696-0.0161QC'd by "NCI"0
Inactive04-0.00830.0949-0.2516-0.1363-0.3201-0.0083QC'd by "NCI"0
Inactive040.1281-0.3790.11360.0866-0.02890.1281QC'd by "NCI"0
Inactive04-0.0989-0.0902-0.1041-0.2289-0.1987-0.0989QC'd by "NCI"0
Inactive040.0739-0.0110.01860.02430.02880.0739QC'd by "NCI"0
Inactive04-0.20280.08760.015-0.0122-0.012-0.2028QC'd by "NCI"0
Inactive04-0.152-0.0722-0.03940.08260.0334-0.152QC'd by "Chembridge"0
Inactive04-0.0720.1489-0.00810.015-0.0036-0.072QC'd by "NCI"0
Inactive04-0.1159-0.19220.11950.16620.2987-0.1159QC'd by "NCI"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: epac2-inhibitor-v2
Protocol: Briefly, three uL of reagents (100 nM EPAC2, 250 nM RAP1B-BODIPY-GDP, 50 uM GDP) were dispensed into a 1536-well Greiner black solid-bottom medium binding assay plate. Controls and test compounds (23 nL) were transferred to the plate via a Kalypsys pin tool equipped with a 1536-pin array. The plates were centrifuged at 1,000 rpm for 15 seconds followed by 5 minute incubation at room temperature. The assay plates were read at 5 minute intervals for 30 minutes in the ViewLux plate reader using 480nm excitation and 540nm emission filters. The results were normalized to the agonist positive control of 6.5 mM cAMP.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods.

Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, with a ratio activity curve class of 4, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. For a ratio activity curve class = -1.1, score = 80+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 && abs(ratio.max_response) > 6*10, score = 60+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -2.1 || ( ratio.curve_class==-2.2 && abs(ratio.max_response) > 6*10), score = 40+abs((log_ac50+4.5)*inf_activity/20). For ratio.curve_class == -1.2 || ratio.curve_class == -2.2, score = 20+abs((log_ac50+4.5)*inf_activity/20). Inconclusive compounds, with a donor curve class other than 4, have PUBCHEM_ACTIVITY_SCORE of 10. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0009200000 uMActivity at 0.00184 uMActivity at 0.00456 uMActivity at 0.00471 uMActivity at 0.00850 uMActivity at 0.018 uMActivity at 0.034 uMActivity at 0.050 uMActivity at 0.090 uMActivity at 0.151 uMActivity at 0.235 uMActivity at 0.457 uMActivity at 0.814 uMActivity at 1.171 uMActivity at 2.284 uMActivity at 4.113 uMActivity at 5.853 uMActivity at 11.42 uMActivity at 20.49 uMActivity at 29.59 uMActivity at 56.64 uMActivity at 111.7 uMActivity at 150.6 uMActivity at 238.8 uMActivity at 452.6 uMActivity at 611.0 uMCompound QC
Inactive03.62720.8626-16.9749340 0 0 0 0 0-11.35224.4122-0.18693.8551-9.0486-22.4791-11.3522QC'd by SigmaAldrich
Inactive01.210.9115126.540 0 0 0 0 03.087922.522231.966122.849617.27176.55893.0879QC'd by NCI
Inactive00.30.7243-12.89953840 0 0 0 0 0-10.749628.516821.95465.20966.073811.3009-10.7496QC'd by Prestwick Chemical; Inc.
Inactive04.95490.8029-15.6993-1.540 0 0 0 0 0-11.416-1.5504-1.249-4.6581-0.42660.4639-11.416QC'd by BIOMOL
Inactive04.95490.6678-24.46023.435940 0 0 0 0 1-5.46512.8722.434-38.4104-25.2406-9.2436-5.4651QC'd by BIOMOL
Inactive02.40640.421511740 0 0 0 0 05.872919.320214.88288.633224.90711.29795.8729QC'd by BIOMOL
Inactive00.60.7078-8.313814.540 0 0 0 0 0-10.777711.81871.99321.9062-11.5115-0.0866-10.7777QC'd by BIOMOL
Inactive03.990.91612.52940 0 0 0 0 011.321625.351110.278212.692812.042515.059611.3216QC'd by BIOMOL
Inactive04.95490.7598-8.0307240 0 0 0 0 0-6.9632-1.91335.8317-9.609-8.7246-6.018-6.9632QC'd by SigmaAldrich
Inactive00.70.6402-18.8089-2.373540 0 0 0 0 0-14.8407-3.9662-6.7181-0.3112-9.968-9.2615-14.8407QC'd by Microsource
Inactive04.95490.9739-11.7501240 0 0 0 0 0-11.69293.0780.24372.2683-12.7084-10.568-11.6929QC'd by Microsource
Inactive00.50.7605-11.0605640 0 0 0 0 0-14.63373.6876-3.5123-6.8473-7.5675-5.2666-14.6337QC'd by BIOMOL
Inactive04-7.534.7778-6.7829-15.1322-23.6499.0847-7.53QC'd by Prestwick Chemical; Inc.
Inactive04.95490.6409-3.29491440 0 0 0 0 112.981817.6514.10220.62192.497-3.579112.9818QC'd by BIOMOL
Inactive01.82650.7407-32.7287-10.937340 0 0 0 0 0-28.3802-13.7631-19.1044-5.7811-12.8137-32.2739-28.3802QC'd by Tocris
Activator39.810746.5380Single point of activity-4.44.44950.745456.645810.107830 0 0 0 0 117.141513.503225.583214.4646.953849.110217.1415QC'd by SigmaAldrich
Inactive04.95490.5359-17.72063.540 0 0 0 0 0-16.8505-6.86613.1002-5.400912.3928-11.0619-16.8505QC'd by SigmaAldrich
Inactive04.95490.6571.108210.540 0 0 0 0 110.717211.35185.125315.2488-0.32652.247610.7172QC'd by Prestwick Chemical; Inc.
Inactive00.70.842-14.440710.540 0 0 0 0 0-8.700613.02386.27927.28923.56910.9878-8.7006QC'd by BIOMOL
Inactive01.010.87182.4065-26.947540 0 0 0 0 1-20.1909-25.9748-30.373-20.9376-21.2882-7.9946-20.1909QC'd by Prestwick Chemical; Inc.
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC478MB
Protocol: Tox21 Assay Protocol Summary:

5 uL of culture medium (MEM containing 10% FBS) per well was dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). After 23 nL compound or DMSO vehicle was transferred into assay plate by a pintool work station (Kalypsys, San Diego, CA), fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.1115-0.1251-0.0765-0.06640.0949-0.1115QC'd by "SIGMA"0
Inactive04-0.0069-0.10850.02610.0208-0.0462-0.0069QC'd by "SigmaAldrich"0
Inactive04-0.172-0.0309-0.0124-0.0718-0.0262-0.172QC'd by "SIGMA"0
Inactive040.0130.0073-0.01730.01340.00240.013QC'd by "SigmaAldrich"0
Inactive04-0.052-0.0612-0.0736-0.0496-0.0413-0.052QC'd by "SigmaAldrich"0
Inactive04-0.0569-0.01650.10050.1139-0.0959-0.0569QC'd by "SigmaAldrich"0
Inactive04-0.0353-0.0623-0.04670.00960.0134-0.0353QC'd by "SIGMA"0
Inactive040.22820.00980.01520.0163-0.02330.2282QC'd by "Alfa Aesar"0
Inactive04-0.1287-0.0353-0.0866-0.012-0.0014-0.1287QC'd by "SIGMA"0
Inactive04-0.0565-0.1141-0.0255-0.009-0.0415-0.0565QC'd by "SIGMA"Inactive04
Inactive04-0.1244-0.1158-0.0769-0.0272-0.0887-0.1244QC'd by "SIGMA"0
Inactive04-0.1459-0.077-0.0696-0.0992-0.1072-0.1459QC'd by "SIGMA"0
Inactive04-0.0112-0.12120.0729-0.0657-0.1082-0.0112QC'd by "SIGMA"0
Inactive04-0.0758-0.1319-0.0931-0.0564-0.0431-0.0758QC'd by "SIGMA"0
Inactive04-0.0061-0.0301-0.0049-0.0052-0.0205-0.0061QC'd by "SigmaAldrich"0
Inactive040.06630.0020.1992-0.0417-0.05850.0663QC'd by "SigmaAldrich"0
Inactive040.1620.0128-0.0595-0.0493-0.05030.162QC'd by "Interchem"0
Inactive04-0.0217-0.0781-0.08430.00810.004-0.0217QC'd by "SigmaAldrich"0
Inactive040-0.0307-1.0E-4-0.0089-0.03580QC'd by "SigmaAldrich"0
Inactive04-0.02990.0039-0.03650.0192-0.0786-0.0299QC'd by "SigmaAldrich"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 3A
External ID: CHEMBL5291824
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL1899
ChEMBL Target Name: Serotonin 3a (5-HT3a) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
2.1AC50=2100nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC478CR
Protocol: Tox21 Assay Protocol Summary:

2,000 HepG2 cells in 5 uL of culture medium (MEM containing 10% FBS) per well were dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). The assay plates were incubated overnight at 37 C to allow cell attachment to the well bottom, followed by the transfer of 23 nL compound or DMSO vehicle by a pintool work station (Kalypsys , San Diego, CA). After the assay plates were incubated for 1 hr at 37 C and 5% CO2, fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590 nm respectively.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.77120.05930.0635-0.0984-0.218-0.7712QC'd by "Prestwick Chemical; Inc."0
Inactive040.28480.45950.13770.23990.45920.2848QC'd by "Prestwick Chemical; Inc."0
Inactive040.10910.08720.002-0.128-0.01040.1091QC'd by "Prestwick Chemical; Inc."0
Inactive040.35690.44360.30790.14920.38140.3569QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.4718-0.21590.1141-0.2538-0.4782-0.4718QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.7519-0.0052-0.0382-0.3499-0.5531-0.7519QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.3026-0.176-0.2919-0.2217-0.1667-0.3026QC'd by "Prestwick Chemical; Inc."0
Inactive040.00260.10340.01420.20370.21520.0026QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.309-0.54610.3903-0.3625-0.0293-0.309QC'd by "Prestwick Chemical; Inc."0
Inactive040.1015-0.23980.08980.41030.37930.1015QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.02650.19180.1501-0.07350.0724-0.0265QC'd by "Prestwick Chemical; Inc."0
Inactive040.3519-0.54170.1370.20740.37870.3519QC'd by "Prestwick Chemical; Inc."0
Inactive040.11140.07490.32080.3560.48040.1114QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.45320.0227-0.0204-0.4367-0.3391-0.4532QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.4937-0.7632-0.0181-0.4913-0.1598-0.4937QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.2868-0.3361-0.3349-0.465-0.3474-0.2868QC'd by "Prestwick Chemical; Inc."0
Inactive040.33880.03910.14580.56180.08170.3388QC'd by "Prestwick Chemical; Inc."0
Inactive040.5747-0.55850.02420.36260.57350.5747QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.3048-0.2054-0.3202-0.3697-0.1434-0.3048QC'd by "Prestwick Chemical; Inc."0
Inactive04-0.27210.25420.1392-0.3556-0.4304-0.2721QC'd by "Prestwick Chemical; Inc."0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 2C
External ID: CHEMBL5291823
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL225
ChEMBL Target Name: Serotonin 2c (5-HT2c) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
6.8AC50=6800nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
5.4AC50=5400nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC478CG
Protocol: Tox21 Assay Protocol Summary:

2,000 HepG2 cells in 5 uL of culture medium (MEM containing 10% FBS) per well were dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (ThermoFisher Scientific, Waltham, MA). The assay plates were incubated overnight at 37 C to allow cell attachment to the well bottom, followed by the transfer of 23 nL compound or DMSO vehicle by a pintool work station (Kalypsys , San Diego, CA). After the assay plates were incubated for 1 hr at 37 C and 5% CO2, fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590 nm respectively.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.0029-0.0082-0.00260.13990.0699-0.0029QC'd by "SIGMA"0
Inactive04-0.10090.004-0.1385-0.05520.0167-0.1009QC'd by "ChromaDex"0
Inactive04-0.00270.04690.0106-0.0323-0.0264-0.0027QC'd by "SIGMA"0
Inactive040.0680.04520.00930.1349-0.05650.068QC'd by "SigmaAldrich"0
Inactive04-0.01020.00830.0497-0.0368-0.1188-0.0102QC'd by "Sensient"0
Inactive040.16110.01260.0217-0.06560.10580.1611QC'd by "Pfaltz-Bauer"0
Inactive040.01860.00820.0242-0.11250.1760.0186QC'd by "SigmaAldrich"0
Inactive040.0141-0.0188-0.03030.00210.09840.0141QC'd by "SigmaAldrich"0
Inactive04-0.06960.0137-0.0094-0.0575-0.0122-0.0696QC'd by "SigmaAldrich"0
Inactive04-0.0879-0.00670.1326-0.0156-0.0041-0.0879QC'd by "SigmaAldrich"0
Inactive040.0162-0.0159-0.0079-0.01810.08710.0162QC'd by "SigmaAldrich"0
Inactive040.02930.0807-0.0391-0.1788-0.09160.0293QC'd by "SIGMA"0
Inactive04-0.0528-0.0224-0.08430.0049-0.0082-0.0528QC'd by "SIGMA"0
Inactive040.11520.05240.1778-0.0592-0.05560.1152QC'd by "SIGMA"0
Inactive04-0.03240.04210.01430.01780.0302-0.0324QC'd by "SIGMA"0
Inactive04-0.1527-0.0095-0.1287-0.0855-0.0912-0.1527QC'd by "SIGMA"0
Inactive040.1560.0209-0.00190.010.00660.156QC'd by "SIGMA"0
Inactive040.0052-0.00170.0141-0.07196.0E-40.0052QC'd by "SIGMA"0
Inactive04-0.0288-0.0779-0.0066-0.0587-0.0039-0.0288QC'd by "SIGMA"0
Inactive04-0.0014-0.08470.0444-0.017-0.0041-0.0014QC'd by "SigmaAldrich"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:NCGC 靶标:
External ID: HERG01
Protocol: NCGC Assay Protocol Summary:

HERG assay (FluxORTM thallium flux assay) was initially developed by Invitrogen/Molecular Probes, and then miniaturized into 1536-well plate in a homogeneous format by NCGC. This assay measures the activity of potassium channel using thallium dye (FluxOR) flux as surrogate measurement for potassium into the cells with a FDSS-7000 kinetic plate reader (Hamamatsu Corp., Hamamatsu City, Japan). The hERG ion channel is transduced into mammalian cells (U2OS) using a baculovirus (Bacmam) construct harboring the hERG K+ ion channel. So far we screened LOPAC1280 library (Sigma), the NTP collection of 1408 compounds, and the NCGC Pharmaceutical Collection (NPC), in which many well defined HERG blockers are present. The rank order potencies of many of these compounds are similar to that of other HERG assays (membrane potential, Rb+ flux, patch clamp, etc). This quick and homogeneous assay is also found to be sensitive, specific, and robust.

Using the FluxORTM thallium flux assay, the activity of potassium channel using thallium dye (FluxOR) flux as surrogate measurement for potassium into the cells was measured in the U2OS cell line transduced with hERG K+ ion channel using a baculovirus (Bacmam) using Opti-MEM medium (Invitrogen) containing 2% fetal calf serum (FCS, HyCone) following loading buffer addition, compound treatment for around 10 minutes and finally adding stimulation buffer. The assay was performed in black clear Kalypsys 1536-well plates. In the screen, Astemizole was used as positive controls. Library compounds were measured for their ability to cause hERG channel blockage in the cell line, as reflected by a decrease in fluorescence intensity, in a concentration-dependent manner. Data were normalized to the controls for basal activity (DMSO only) and 100% inhibition (5uM Astemizole). AC50 values were determined from concentration-response data modeled with the standard Hill equation.

qHTS protocol for hERG-U2OS cellular assay

[Step] [Parameter] [Value] [Description]

1. Day 1: Replace medium in 70-80% confluent T225 flask with 2.5 mL of hERG-BacMam virus plus 12.5 mL of phosphate buffered saline (PBS) (corresponding roughly to a multiplicity of infection ratio of 100 virus particles/cell)
2. Incubation: 4 hrs @ room Temperature in Dark
3. Reagent; Remove virus; wash once with 25 ml DPBS
4. Reagent; 35 ml culture medium
5. Incubation; 37oC overnight
6. Day2: Reagent; 3 uL; 2000 U2OS cells/well
7. Time; 4 hr; 37oC incubation
8. Loading buffer; 1 uL; 0.7X;
9. Incubation: 1hr @ RT in Dark.
10. Compounds; 23 nL; 0.59 nM to 92 uM
11. Controls; 23 nL; Astemizole 1.4 nM to 92 uM
12. Time; 10min; 37oC incubation
13. Read fluorescence Intensity on FDSS for 10 Sec with 1 sec interval
14. Reagent; 1 uL; stimulation buffer
15. Read fluorescence Intensity on FDSS for 2 min with 1 sec interval
16. Detection; Fluorescence Intensity; FDSS
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
PhenotypePotencyEfficacyAnalysis CommentActivity_ScoreCurve_DescriptionFit_LogAC50Fit_HillSlopeFit_R2Fit_InfiniteActivityFit_ZeroActivityFit_CurveClassExcluded_PointsMax_ResponseActivity at 0.0001000000 uMActivity at 0.0003000000 uMActivity at 0.0006116734 uMActivity at 0.00133 uMActivity at 0.00297 uMActivity at 0.00673 uMActivity at 0.015 uMActivity at 0.033 uMActivity at 0.075 uMActivity at 0.167 uMActivity at 0.369 uMActivity at 0.412 uMActivity at 0.836 uMActivity at 1.842 uMActivity at 2.061 uMActivity at 4.179 uMActivity at 9.216 uMActivity at 20.61 uMActivity at 46.08 uMActivity at 92.17 uMCompound QC
Inactive04.0950.5622-0.5-17.405541 0 0 0 0 0 1 0 0 0 0 0 0 04.0358-8.1088-16.5879-0.7265-5.65844.3730.1327-9.70320.36854.1527-0.141-3.5272-0.9713-9.32034.0358QC'd by NIEHS/NTP
Activator15.848952.39750Single point of activity-4.80.40.510848.9806-3.416930 0 0 0 0 1 0 0 0 0 0 1 0 1 038.06212.0116-8.9739-7.06230-7.0944-39.2396018.733825.780800-59.539411.623748.215338.0621QC'd by NIEHS
Inactive04-1.0832-10.89741.0031-11.058-11.8883.65680.91825.31740.029-1.48932.17113.0788-19.8367-2.8584-1.0832QC'd by NIEHS/NTP
Inactive042.45982.223-1.63678.778-0.11389.22693.440711.6742-2.146511.8823-1.8078-2.0833.78254.49092.4598QC'd by NIEHS
Inactive01.85790.45754.5-21.089940 0 0 0 0 0 0 0 0 0 0 0 0 012.886-15.90830.10180.3771-0.02467.9993-3.79713.097311.63728.3022-2.66639.3202-2.3421-0.285412.886QC'd by NIEHS/NTP
Inactive04.95490.5492-6.77071.540 0 0 0 0 0 0 0 0 0 1 0 0 11.3669-1.0856-0.77651.12421.70580.7901-1.98696.09015.26593.2331-7.9279-28.3694-1.3017-10.22551.3669QC'd by NIEHS/NTP
Inactive04-5.5826-4.0359-4.4476-11.3473-11.9097-1.5507-10.1535-3.36261.3234-0.4426-13.9824-5.2512-18.0387-15.3022-5.5826QC'd by NIEHS/NTP
Inhibitor39.810751.900420Partial curve; partial efficacy-4.43.990.9828-50.13811.7623-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0-49.45943.1993-0.02692.7134-1.98075.29460.2133-0.1387-0.26252.47080.17772.53720.4925-30.4729-49.4594QC'd by NIEHS/NTP
Inactive02.33320.6977-10.8456140 0 0 0 0 0 1 0 0 0 0 1 0 1-1.1266-1.46111.2528-0.03690.02955.5889-3.03576.75064.5747-1.4797-0.1821-9.6414-1.4402-9.8713-1.1266QC'd by NIEHS/NTP
Inactive0414.60080.5397-1.6708-0.4130.96947.4259-2.25855.08697.9351-2.4752-5.6365.39961.849-2.487114.6008QC'd by NIEHS/NTP
Inactive00.70.5791-8.9231440 0 0 0 0 0 1 0 0 0 0 0 0 12.80633.51535.19381.41166.33634.612.742912.44016.0481-0.14110.3707-1.47812.4968-5.76932.8063QC'd by NIEHS/NTP
Inactive04-17.8369-10.5115-2.5586-8.8158-26.0957-0.4819-9.7892-2.01490.27332.7166-17.2183-0.47591.0932-12.7028-17.8369QC'd by NIEHS/NTP
Inactive04.95490.4427-9.7222-1.541 0 1 0 0 0 0 0 0 0 0 0 0 0-13.1018-5.53920.00687.73370.45884.0455-12.3759-6.57240.92181.9145-11.3469-7.6261-8.5179-8.6226-13.1018QC'd by NIEHS/NTP
Inactive03.1320.7434-16.07841.540 0 0 0 0 0 0 0 0 0 0 0 0 13.99653.3921-1.15561.97152.01773.8894-2.6092.87572.72384.1025-3.54462.1635-3.6983-12.9823.9965QC'd by NIEHS/NTP
Inactive047.53724.3881-20.20115.5178-1.37582.0045-1.44014.9593-2.11221.3726-3.0011-3.06771.18832.18177.5372QC'd by NIEHS/NTP
Inactive0411.45250.2692-0.1403-0.3748-11.74892.8347-5.054616.89840.0513.829-3.6094-0.51978.0326-1.547611.4525QC'd by NIEHS/NTP
Inactive049.99361.71397.16916.3352-0.34329.148-5.8673-1.564112.6111.82378.2616-0.66541.73632.63199.9936QC'd by NIEHS/NTP
Inactive0410.2340.52521.3877-1.9626-0.9425.6494-0.276911.70528.3766.8657-0.149-0.19442.6788-6.419210.234QC'd by NIEHS/NTP
Activator22.387233.89380Complete curve; partial efficacy; poor fit-4.652.25260.715133.99630.10251.40 0 0 0 0 0 0 0 0 0 0 0 0 025.52240.4272-0.9219-0.128-2.10618.1765-1.5863-10.226512.16486.8628-0.3193-6.515517.608732.268925.5224QC'd by NIEHS/NTP
Inactive049.98485.58260.0396-1.5504-1.30043.2953.988212.27428.06469.11922.031.29227.4225-2.99749.9848QC'd by NIEHS/NTP
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Severe acute respiratory syndrome coronavirus 2
External ID: CHEMBL4303805
Protocol: N/A
Comment: Target ChEMBL ID: CHEMBL4303835
ChEMBL Target Name: SARS-CoV-2
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: SARS-CoV-2 Screening Data
Standard TypeStandard RelationStandard ValueStandard UnitsData Validity Comment
Inhibition=-11.52%Outside typical range
Inhibition=5.09%
Inhibition=-1.71%
Inhibition=3.69%
Inhibition=22.47%
Inhibition=8.51%
Inhibition=-6.86%
Inhibition=-6.18%
Inhibition=-2.07%
Inhibition=3.91%
Inhibition=-5.9%
Inhibition=-2.45%
Inhibition=-5.55%
Inhibition=6.31%
Inhibition=-1.08%
Inhibition=12.7%
Inhibition=0.37%
Inhibition=8.88%
Inhibition=11.63%
Inhibition=-1.96%
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC167CB
Protocol: Tox21 Assay Protocol Summary:

2,000 HEK293 cells in 5 uL of culture medium containing 10% dialyzed FBS per well were dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (Thermo Scientific). The assay plates were incubated for 4-5 hr at 37C to allow cell attachment to the well bottom, followed by the transfer of 23 nL compound or DMSO vehicle by a pintool work station (Kalypsys, San Diego, CA). After the assay plates were incubated overnight at 37C and 5% CO2, fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.0993-0.0315-0.0456-0.0314-0.0445-0.0993QC'd by "SIGMA"0
Inactive04-0.0413-0.330.9732-0.1408-0.2626-0.0413QC'd by "SIGMA"0
Inactive043.0E-4-0.0951-0.0908-0.0608-0.01023.0E-4QC'd by "SIGMA"0
Inactive040.00362.0E-4-0.1154-0.1852-0.02580.0036QC'd by "SIGMA"0
Inactive04-0.08410.02920.0072-0.0606-0.0747-0.0841QC'd by "SIGMA"0
Inactive04-0.0562-0.02190.0027-0.0792-0.1435-0.0562QC'd by "SIGMA"0
Inactive04-0.0228-0.2225-0.17238.0E-4-0.2899-0.0228QC'd by "SIGMA"0
Inactive04-0.10910.0012-0.0968-0.007-0.2223-0.1091QC'd by "SIGMA"0
Inactive04-0.03890.07040.0162-0.0035-0.0387-0.0389QC'd by "SIGMA"0
Inactive040.0777-0.1888-0.0421-0.0179-0.13070.0777QC'd by "SIGMA"0
Inactive04-0.1076-0.1771-0.0039-0.04160.0041-0.1076QC'd by "SIGMA"0
Inactive04-0.0441-0.05340.0039-0.0433-0.1015-0.0441QC'd by "TCI"0
Inactive04-0.42250.18470.0082-0.0822-0.0703-0.4225QC'd by "SIGMA"0
Inactive040.0630.0914-0.00420.0899-0.04430.063QC'd by "SIGMA"0
Inactive040.21370.17290.0260.23310.10530.2137QC'd by "SIGMA"0
Inactive04-0.0274-0.01920.12090.04090.0156-0.0274QC'd by "SIGMA"0
Inactive040.0634-0.01480.0720.08030.08560.0634QC'd by "SIGMA"0
Inactive040.0335-0.04990.1012-0.00170.26310.0335QC'd by "SIGMA"0
Inactive04-0.0334-0.0211-0.0049-0.03310.19-0.0334QC'd by "SIGMA"0
Inactive040.15920.01470.11910.10190.12680.1592QC'd by "SIGMA"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 2B
External ID: CHEMBL5291819
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL1833
ChEMBL Target Name: Serotonin 2b (5-HT2b) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SPEC167CR
Protocol: Tox21 Assay Protocol Summary:

2,000 HEK293 cells in 5 uL of culture medium containing 10% dialyzed FBS per well were dispensed into black wall/clear bottom 1536-well plates using a Multidrop Combi Dispenser (Thermo Scientific). The assay plates were incubated for 4-5 hr at 37C to allow cell attachment to the well bottom, followed by the transfer of 23 nL compound or DMSO vehicle by a pintool work station (Kalypsys, San Diego, CA). After the assay plates were incubated overnight at 37C and 5% CO2, fluorescence intensities in the assay plates were measured by an Envision (PerkinElmer, Shelton, CT) plate reader using three labels for measuring blue, green and red fluorescence at excitations 460, 535 and 590nm respectively.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0005530000 uM-Replicate_1Activity at 0.00276 uM-Replicate_1Activity at 0.00765 uM-Replicate_1Activity at 0.012 uM-Replicate_1Activity at 0.024 uM-Replicate_1Activity at 0.034 uM-Replicate_1Activity at 0.074 uM-Replicate_1Activity at 0.148 uM-Replicate_1Activity at 0.199 uM-Replicate_1Activity at 0.370 uM-Replicate_1Activity at 0.743 uM-Replicate_1Activity at 1.207 uM-Replicate_1Activity at 1.859 uM-Replicate_1Activity at 3.722 uM-Replicate_1Activity at 9.170 uM-Replicate_1Activity at 13.42 uM-Replicate_1Activity at 18.62 uM-Replicate_1Activity at 45.97 uM-Replicate_1Activity at 91.34 uM-Replicate_1Activity at 95.67 uM-Replicate_1Activity at 202.9 uM-Replicate_1Activity at 354.0 uM-Replicate_1Activity at 920.3 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2Fit_ZeroActivity-Replicate_2Fit_CurveClass-Replicate_2
Inactive04-0.1742-0.0105-0.0707-0.708-0.8608-0.1742QC'd by "NCI"0
Inactive04-0.15950.087-0.0389-0.0424-0.0089-0.1595QC'd by "NCI"0
Inactive040.17150.56230.2590.06620.03240.1715QC'd by "NCI"0
Inactive040.04060.1038-4.0E-40.08940.12640.0406QC'd by "SigmaAldrich"0
Inactive040.439-0.1165-0.2370.53740.0650.439QC'd by "NCI"0
Inactive04-0.1787-0.0681-0.0763-0.05880.0674-0.1787QC'd by "NCI"0
Inactive04-0.26880.03020.2349-0.1201-0.1287-0.2688QC'd by "NCI"0
Inactive04-0.1086-0.2195-0.0573-0.14660.1358-0.1086QC'd by "NCI"0
Inactive04-0.1833-0.03-0.0379-0.4701-0.1431-0.1833QC'd by "NCI"0
Inactive04-0.9523-1.1611-0.9118-1.0013-1.0781-0.9523QC'd by "Labotest"0
Inactive04-0.2307-0.10680.4032-0.0433-0.0679-0.2307QC'd by "NCI"0
Inactive040.06170.30390.1775-0.00510.08570.0617QC'd by "NCI"0
Inactive04-0.1350.1614-0.083-0.1721-0.0432-0.135QC'd by "NCI"0
Inactive040.2214-0.6929-0.11650.0685-0.05560.2214QC'd by "NCI"0
Inactive04-0.2027-0.05290.0564-0.9701-0.3154-0.2027QC'd by "NCI"0
Inactive040.06990.0444-0.03810.03760.19960.0699QC'd by "NCI"0
Inactive040.0459-0.04550.12930.11980.02850.0459QC'd by "NCI"0
Inactive04-0.0306-0.0309-0.01430.02940.0175-0.0306QC'd by "Chembridge"0
Inactive04-0.02680.23620.2368-0.0791-0.0097-0.0268QC'd by "NCI"0
Inactive040.0114-0.9843-0.7454-0.13590.21030.0114QC'd by "NCI"0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 2B
External ID: CHEMBL5291821
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL1833
ChEMBL Target Name: Serotonin 2b (5-HT2b) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.03AC50=30nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
5AC50=5000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
2AC50=2000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
16AC50=16000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
23.0651AC50=23065.1nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
23.0001AC50=23000.1nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
20AC50=20000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
5.6AC50=5600nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 2A
External ID: CHEMBL5291816
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL224
ChEMBL Target Name: Serotonin 2a (5-HT2a) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 2A
External ID: CHEMBL5291817
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL224
ChEMBL Target Name: Serotonin 2a (5-HT2a) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.07AC50=70nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50=10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
2.8AC50=2800nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
17.9999AC50=17999.9nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
0.9AC50=900nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 1A
External ID: CHEMBL5291814
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL214
ChEMBL Target Name: Serotonin 1a (5-HT1a) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
6.9AC50=6900nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
4.8AC50=4800nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:5-hydroxytryptamine receptor 1A
External ID: CHEMBL5291813
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL214
ChEMBL Target Name: Serotonin 1a (5-HT1a) receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
4.4AC50=4400nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: GRA481
Protocol: Tox21 Assay Protocol Summary:

The GR-bla HeLa cells were dispensed at 1500 cells/6 ul/well in 1536-well black wall/clear bottom plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 4 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pintool station (Kalypsys, San Diego, CA). The plates were incubated at 37 C for 18 hours. After 1 uL of LiveBLAzerTM B/G FRET substrate was added using a Flying Reagent Dispenser (Aurora Discovery, San Diego, CA), the plates were incubated at room temperature for 2 hours, and fluorescence intensity was measured by an Envision plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W460-Activity_Score-Replicate_1W460-Curve_Description-Replicate_1W460-Fit_LogAC50-Replicate_1W460-Fit_HillSlope-Replicate_1W460-Fit_R2-Replicate_1W460-Fit_InfiniteActivity-Replicate_1W460-Fit_ZeroActivity-Replicate_1W460-Fit_CurveClass-Replicate_1W460-Excluded_Points-Replicate_1W460-Max_Response-Replicate_1W460-Activity at 0.0000036780 uM-Replicate_1W460-Activity at 0.0000082250 uM-Replicate_1W460-Activity at 0.0000183900 uM-Replicate_1W460-Activity at 0.0000514703 uM-Replicate_1W460-Activity at 0.0001157795 uM-Replicate_1W460-Activity at 0.0002347639 uM-Replicate_1W460-Activity at 0.0005064679 uM-Replicate_1W460-Activity at 0.00101 uM-Replicate_1W460-Activity at 0.00226 uM-Replicate_1W460-Activity at 0.00505 uM-Replicate_1W460-Activity at 0.011 uM-Replicate_1W460-Activity at 0.025 uM-Replicate_1W460-Activity at 0.056 uM-Replicate_1W460-Activity at 0.125 uM-Replicate_1W460-Activity at 0.280 uM-Replicate_1W460-Activity at 0.624 uM-Replicate_1W460-Activity at 1.391 uM-Replicate_1W460-Activity at 3.095 uM-Replicate_1W460-Activity at 6.900 uM-Replicate_1W460-Activity at 15.01 uM-Replicate_1W460-Activity at 29.18 uM-Replicate_1W460-Activity at 62.39 uM-Replicate_1W460-Activity at 79.15 uM-Replicate_1W460-Activity at 213.3 uM-Replicate_1W460-Activity at 765.1 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1Ratio-Activity at 0.0000036780 uM-Replicate_1
Inactive040.7562-2.0191-2.8763-0.9026-3.551-0.7809-0.2770.3016-2.05597.6695-0.4571-0.4785-0.3067-3.19312.29950.7562102.72020.5091-13.21010.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-2.8015
Inconclusive2.683243.355504.95490.33697-1.259840 0 0 0 0 0 0 0 0 0 0 0 0 0 05.13651.0101-0.5652-4.3951-0.2458-3.9615-0.72250.0703-5.2165-4.71332.5855-0.82580.39810.8412-1.08125.1365103.06540.430911-0.15540 0 0 0 0 0 0 0 0 0 0 0 0 0 010.4779
Inactive00.9310.515-2.2498140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.19170.0432-0.94582.66191.9187-0.00912.6540.7197-0.8071-0.0436-0.1456-2.86940.2333-3.1248-1.627-2.19171040.5349
Cytotoxic23.914564.59580Partial curve; partial efficacy-4.72133.1320.9596-43.45790.2745-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-39.3622.89331.82591.0907-0.1463-0.10590.92180.09150.19131.3078-6.7647-0.7119-0.62320.4675-17.992-39.362100.30.5041-9.1529140 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6116
Inactive00.50.455-21.31571.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.42971.0157-1.7522.7232.69846.869-3.71430.19816.1321-2.0281-8.9254-4.3551-0.3757-5.1288-2.2826-14.4297100.20.470911.5-5.046140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-2.922
Inconclusive15.08948.866903.51170.44866.5-1.011940 0 0 0 0 0 0 0 0 0 0 0 0 0 05.50351.07060.905-0.25830.69930.4392-0.1511-3.58922.2605-4.5752-0.49010.3402-2.2626-5.42666.35045.5035103.1320.5006-12.72791.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.019
Activator0.095244.78110Single point of activity-7.02134.95490.971588.6934-1.347630 0 0 0 0 0 0 0 1 1 1 1 1 1 1-0.2744-4.73250.61890.21280.81980.5686-0.35281.205386.9543-3.9984-3.1116-0.3361-4.4875-4.0498-7.4011-0.27440Single point of activity-7.02134.95490.969543.878-0.903130 0 0 0 0 0 0 0 1 1 1 1 1 1 1-0.1232
Inactive043.93180.3895-0.21130.182-0.9258-0.4412-3.95122.1721-0.1688-5.0997-0.15442.3995-4.165-0.19191.89093.9318104-1.6204
Inactive04.95490.4549-2.1971140 0 0 0 0 0 0 0 0 0 0 0 0 0 10.39480.2258-0.38513.3271.6718-0.0652.57751.6671-0.09210.011-0.24882.0368-2.0108-3.4976-0.2290.3948103.51170.49812-0.310640 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.5444
Inactive04.95490.49990.779540 0 0 0 0 0 0 0 0 0 0 0 0 0 07.19890.56481.7838-0.99043.56074.2105-1.85041.559-0.7889-0.57311.13450.3821.1458-0.6344-0.05567.19891043.2539
Inconclusive26.832542.156903.1320.6237-18.228140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.8509-0.43261.3737-0.723-1.5954-0.98793.3248-0.25092.6333-1.3551-3.191.65445.081210.7255-16.44-14.85090Complete curve; partial efficacy; poor fit-5.32134.95490.903616-1.39761.40 0 0 0 0 0 0 0 0 0 0 0 0 1 014.2731
Inactive01.3310.44069-1.315540 0 0 0 0 0 0 0 0 0 0 0 0 0 07.7682-8.1796-1.2864-0.92690.0489-1.1023.6629-5.3855-2.0892-3.4173.63520.2376-0.11450.36824.02527.7682104.0950.645512.50.056140 0 0 0 0 0 0 0 0 0 0 0 0 0 013.4789
Inactive04-1.77665.9446-8.071110.9483-0.66150.7628-0.19420.81740.424-0.04970.3107-1.4675-4.3278-0.9634-3.4067-1.77661040.3915
Cytotoxic30.106580.09980Single point of activity-4.57134.95490.9233-34.1878-1-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-30.15651.4442-1.42590.5602-0.5727-1.5149-1.1531-1.7711-0.5991-1.6507-0.5856-0.7334-2.4262-6.8854-0.1814-30.15650Single point of activity-4.57134.95490.964133.76670.413730 0 0 0 0 0 0 0 0 0 0 0 0 0 0123.858
Inactive04.0950.6978-0.5-7.11540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.8355-7.1792-4.2685-1.14751.1488-2.8672-0.65330.9563-0.5809-0.63290.28570.6351.0765-3.2022-0.934-0.8355104.95490.8946-0.469515.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.4115
Inactive047.6683-0.213812.7411-0.95732.68175.82062.76031.9502-1.1272.6603-0.154-4.84897.2899-0.02820.21517.6683100.70.4452-6.3234340 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.9779
Inactive04.95490.38580-3.382540 0 0 0 0 0 0 0 0 0 0 0 0 0 00.3426-2.7245-4.1769-2.5201-5.3186-0.55251.2952-5.152-6.9854-0.68020.87571.22690.5227-3.0321.11160.3426104-1.3858
Inactive043.5373-0.4222-4.6002-0.5607-0.0671-0.45211.69491.7648-0.6170.1086-4.2139-4.41190.48912.0611-0.44833.5373104-0.2942
Activator10.682283.89470Single point of activity-4.97133.92950.884675.0549-2.701730 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7587-0.7027-0.0356-2.9874-6.5873-2.95230.4426-0.8132-2.168-2.9385-0.9678-1.866-0.243-1.378889.35110.75870Single point of activity-4.97133.990.888280.6868-3.207930 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0157
Inactive043.2274-0.4217-5.36674.2879-0.76117.993-0.6172-2.95230.12040.2389-2.49690.367-2.94147.0059-0.88663.2274103.06540.600216-1.455840 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6692
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Histamine H2 receptor
External ID: CHEMBL5291810
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL1941
ChEMBL Target Name: Histamine H2 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Histamine H1 receptor
External ID: CHEMBL5291809
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL231
ChEMBL Target Name: Histamine H1 receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
15AC50=15000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
1AC50>1000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Growth hormone secretagogue receptor type 1
External ID: CHEMBL5291803
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL4616
ChEMBL Target Name: Ghrelin receptor
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity CommentData Validity Comment
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
2.2AC50=2200nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
22.1998AC50=22199.8nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
18.9998AC50=18999.8nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: GRN257
Protocol: Tox21 Assay Protocol Summary:

The GR-bla HeLa cells were dispensed at 1500 cells/5 ul/well in 1536-well black wall/clear bottom plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 4 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pintool station (Kalypsys, San Diego, CA), followed by addition of 1 uL of dexamethasone (5 nM, final concentration in the well). The plates were incubated at 37 C for 18 hours. After 1 uL of LiveBLAzerTM B/G FRET substrate was added using a Flying Reagent Dispenser (Aurora Discovery, San Diego, CA), the plates were incubated at room temperature for 2 hours, and fluorescence intensity was measured by an Envision plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W460-Activity_Score-Replicate_1W460-Curve_Description-Replicate_1W460-Fit_LogAC50-Replicate_1W460-Fit_HillSlope-Replicate_1W460-Fit_R2-Replicate_1W460-Fit_InfiniteActivity-Replicate_1W460-Fit_ZeroActivity-Replicate_1W460-Fit_CurveClass-Replicate_1W460-Excluded_Points-Replicate_1W460-Max_Response-Replicate_1W460-Activity at 0.0000036780 uM-Replicate_1W460-Activity at 0.0000082250 uM-Replicate_1W460-Activity at 0.0000183900 uM-Replicate_1W460-Activity at 0.0000514202 uM-Replicate_1W460-Activity at 0.0001158387 uM-Replicate_1W460-Activity at 0.0002261535 uM-Replicate_1W460-Activity at 0.0004949824 uM-Replicate_1W460-Activity at 0.00102 uM-Replicate_1W460-Activity at 0.00229 uM-Replicate_1W460-Activity at 0.00510 uM-Replicate_1W460-Activity at 0.011 uM-Replicate_1W460-Activity at 0.025 uM-Replicate_1W460-Activity at 0.057 uM-Replicate_1W460-Activity at 0.127 uM-Replicate_1W460-Activity at 0.284 uM-Replicate_1W460-Activity at 0.634 uM-Replicate_1W460-Activity at 1.415 uM-Replicate_1W460-Activity at 3.154 uM-Replicate_1W460-Activity at 7.040 uM-Replicate_1W460-Activity at 15.11 uM-Replicate_1W460-Activity at 27.01 uM-Replicate_1W460-Activity at 58.48 uM-Replicate_1W460-Activity at 78.95 uM-Replicate_1W460-Activity at 216.1 uM-Replicate_1W460-Activity at 765.1 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1Ratio-Activity at 0.0000036780 uM-Replicate_1
Inactive04-12.097-15.4211.22518.50446.32020.846114.98991.67820.3453-2.12172.5147-17.8498-9.32760.28162.6709-12.097104-12.0519
Inconclusive0Single point of activity-4.52134.95490.372839.41940.385430 0 0 0 0 0 0 0 0 0 0 0 0 0 032.79711.95395.33912.21820.80081.884415.32420.02920.8207-21.1398-1.4369-24.04185.752217.14520.630832.79711040.9716
Inactive04-5.25290.17872.973832.766221.31856.600616.055125.63979.842634.3918-9.8497-0.1044-5.717114.7663-0.7047-5.25291046.6113
Cytotoxic23.914544.75320Partial curve; high efficacy-4.77133.06540.9397-151.36460.7993-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-140.15255.712-11.72013.174311.80043.9627-11.745919.69894.1037-4.89243.0574-21.16290.0911-4.4585-74.4823-140.15250Complete curve; high efficacy-4.97133.51170.8761-65.1981-0.3709-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-64.7954
Inhibitor26.8325102.2380Single point of activity-4.57134.95490.7068-122.91268.4508-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-103.83561.9814-8.2905-0.6801-2.507810.7911-7.456524.81948.5806-7.33822.7627-1.146220.661865.1802-2.288-103.83560Single point of activity-4.57134.95490.8259-97.04015.198-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-85.6797
Inactive043.352-18.3617-0.7198-1.82120.7254-2.3887-0.71138.1346-18.636610.8874-1.88711.636-16.58518.3351-18.83343.3521042.0179
Inconclusive0Complete curve; partial efficacy; poor fit-7.52131.46410.680236.20112.51.41 0 0 0 0 0 0 0 0 0 1 1 1 1 122.057130.60393.688701.975524.92820.940436.70837.549926.490437.73945.076219.601119.7132-3.264822.0571104-2.2828
Inactive043.5852-0.9953.1779-2.90782.9481-0.79636.8681-22.0598-14.2108-2.2977-16.3346-2.03172.00522.18690.90223.5852104-2.9287
Inactive04-2.74024.46784.162900.150523.553338.24690.453-5.2560.55339.8796-0.6274-4.2999023.1032-2.7402104-6.1592
Inactive0417.07540.24292.78673.44132.792-1.4151.419821.8245-2.16183.6162-18.04260.0956-1.3056-2.398512.358417.0754104-11.8022
Cytotoxic26.832542.81820Single point of activity-4.57134.95490.9428-140.4676.5416-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-123.21672.731110.1203-0.9412-0.006715.33822.152318.6872.49431.3665-0.576414.2545-2.3685-1.0992-1.3076-123.21670Partial curve; partial efficacy; poor fit-4.52130.60.588-65.2178-6.1658-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-51.7601
Inconclusive0Partial curve; partial efficacy-4.92131.10.711641.11172.152.20 0 0 0 0 0 0 0 0 0 0 0 0 0 040.5279-2.658815.3997-1.32051.54133.8511.1616-0.54452.66480.16530.4079-0.475322.922612.925317.4440.5279104-1.1211
Inactive045.3983-14.35172.32162.82171.398410.6583-13.337-1.73434.042716.340518.8055-0.856912.351214.0297-4.28015.3983104-15.3874
Cytotoxic26.832560.9510Single point of activity-4.57134.95490.8965-166.924610.764-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-155.4129-4.74481.248714.33939.9359-5.64392.083840.29660.993714.79787.97237.785523.56762.329620.0585-155.41290Single point of activity-4.57134.95490.72-34.1482.3048-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-30.286
Inactive04-17.9221-5.6935-9.7378-15.0242-13.45874.1955-20.9421.6642.78496.2808-1.65063.6358-21.3152-1.5804-17.7116-17.9221104-3.4006
Inactive04-16.0736-0.16670.063414.39452.22271.76036.0139-16.78778.30026.13620.2785-23.70580.041617.93561.9071-16.0736104-0.4858
Inactive00.70.515419.5726-16.145540 0 0 0 0 0 1 0 0 0 0 0 0 0 1-18.9267-14.0001-14.1391-15.825-18.1982-31.1347-5.992124.7447-16.7843-1.0696-18.5346-4.5707-4.9181-7.002213.1558-18.9267104-7.4051
Inactive04-15.437230.19180.87326.82955.19737.68435.82839.8057-1.3433-0.6271-0.7496-16.36081.435420.67980.2025-15.43721040.541
Inactive04-8.09546.20142.679-3.15441.45620.91-3.2719-6.17514.4834-9.2058-3.6067-5.2067-7.29356.5535-11.4671-8.0954104-19.5741
Inconclusive04-6.5078-13.7847-11.6608-0.2953-62.2272-22.8473-5.7475-4.5773-29.0585-18.6043-33.5711-11.69590-23.5243-23.2348-6.50780Single point of activity-4.57134.95490.701639.7004-8.651930 0 0 0 0 0 0 0 0 0 0 0 0 0 036.4575
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Glutamate receptor ionotropic, NMDA 1
External ID: CHEMBL5291805
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Nat Commun
Year: 2023
Volume: 14
Issue: 1
First Page: 1
Last Page: 17
DOI: 10.1038/s41467-023-40064-9

Target ChEMBL ID: CHEMBL330
ChEMBL Target Name: Glutamate (NMDA) receptor subunit zeta 1
ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain
Relationship Type: H - Homologous protein target assigned
Confidence: Homologous single protein target assigned
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
30AC50>30000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
10AC50>10000nMSummarised AC50 (mean value for measurements with a relation sign "="; largest value for measurements with relation sign ">")
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: GRV193
Protocol: Tox21 Assay Protocol Summary:

The GR-bla HeLa cells were dispensed at 1500 cells/5 ul/well in 1536-well black wall/clear bottom plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 4 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pintool station (Kalypsys, San Diego, CA), followed by addition of 1 uL of dexamethasone (5 nM, final concentration in the well). The plates were incubated at 37 C for 18 hours. After 1 uL of LiveBLAzerTM B/G FRET substrate was added using a Flying Reagent Dispenser (Aurora Discovery, San Diego, CA), the plates were incubated at room temperature (RT) for 2 hours, and fluorescence intensity was measured by an Envision plate reader (PerkinElmer, Shelton, CT). After measurement of bla assay, 3 ul CellTiter-Glo (Promega, Madison, WI) was added to measure the cytotoxicity and the plates were then incubated at RT for 30 min. The luminescence was measured using a ViewLux (Perkin Elmer) plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000036780 uM-Replicate_1Activity at 0.0000082250 uM-Replicate_1Activity at 0.0000183900 uM-Replicate_1Activity at 0.0000514202 uM-Replicate_1Activity at 0.0001156673 uM-Replicate_1Activity at 0.0002261535 uM-Replicate_1Activity at 0.0004949824 uM-Replicate_1Activity at 0.00102 uM-Replicate_1Activity at 0.00229 uM-Replicate_1Activity at 0.00510 uM-Replicate_1Activity at 0.011 uM-Replicate_1Activity at 0.025 uM-Replicate_1Activity at 0.057 uM-Replicate_1Activity at 0.127 uM-Replicate_1Activity at 0.284 uM-Replicate_1Activity at 0.634 uM-Replicate_1Activity at 1.415 uM-Replicate_1Activity at 3.154 uM-Replicate_1Activity at 7.040 uM-Replicate_1Activity at 15.11 uM-Replicate_1Activity at 27.01 uM-Replicate_1Activity at 58.48 uM-Replicate_1Activity at 78.95 uM-Replicate_1Activity at 216.1 uM-Replicate_1Activity at 765.1 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2Fit_InfiniteActivity-Replicate_2
Inactive04-8.9896-7.3975-6.7113-14.8241-4.5178-1.517512.264-8.1607-13.49270.92690.0472-1.09210.2383-2.6378-1.9489-8.9896QC'd by SequoiaCytotoxic0.006727.901520Complete curve; partial efficacy; poor fit-8.17134.95490.4115-26.6818
Inactive04-12.8644-12.4335-6.4744-20.0821-10.89713.6433-6.8703-5.7214-9.84543.7236-7.371-2.7049-10.4097-16.8792-5.8495-12.8644QC'd by FLUKAInactive0
Inactive00.60.6935-5.705513.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.93149.184113.869-0.63448.33090.23784.4977-4.6175-6.73290.5376-2.5323-8.0879-5.8972-4.0555-7.5668-2.9314QC'd by FLUKACytotoxic47.715650.274420Partial curve; partial efficacy; poor fit-4.32130.30.4501-54.3952
Inactive0412.0884-2.3949-3.4828-3.133815.632524.520517.03-4.6009-4.4756-1.6879.12462.7279-2.11843.193-0.18912.0884QC'd by BIOMOLInconclusive1.068269.039710Partial curve; partial efficacy; poor fit-5.97130.20.438955.7277
Cytotoxic26.832573.745320Single point of activity-4.57134.95490.8323-69.69384.0515-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-61.368517.6007-1.759413.0949-3.274312.563612.30281.95770.648-6.95350.28381.5448-0.0522-1.42575.7042-61.3685QC'd by BIOMOLCytotoxic21.313893.273741Partial curve; high efficacy-4.67132.90230.9235-86.9043
Inactive046.7909-1.31027.7383-4.547-2.65212.1059-2.4181-1.10118.09747.2420.3477-5.05879.40029.3931-0.87996.7909QC'd by BIOMOLInactive0
Inactive041.4423-3.99322.77927.1221-0.8837-8.95352.295-0.51041.37322.285720.59571.5207-5.3744.2397-11.91461.4423QC'd by BIOMOLInactive0
Inactive00.60.3367-9.79324.540 0 0 0 0 0 0 0 0 0 0 0 0 0 12.02261.3465-0.45472.410510.291411.99868.0638-8.1616.00951.6819-2.0122-2.01511.6093-6.3684-6.20422.0226QC'd by BIOMOLInactive02.47290.378538.7776
Inactive0415.2343-1.80842.058715.92577.90848.0244-2.30815.36692.48331.03819.9575-3.366-5.2227-2.2446-0.160715.2343QC'd by BIOMOLInactive0
Inactive047.9538-1.872810.9648-1.09872.6071-1.078614.35211.0497-1.76951.8577-2.7126-2.4267-0.2948-1.380911.52387.9538QC'd by BIOMOLInconclusive18.995953.670810Partial curve; partial efficacy; poor fit-4.72132.40640.570554.7236
Inactive04.95490.518517.50.289140 0 0 0 0 0 0 0 0 0 0 0 0 0 013.283514.4715-2.8018-2.2504-1.854-1.0751.91726.8822-1.1544-5.5924-0.0354-3.34427.78934.034525.595213.2835QC'd by BIOMOLInactive0
Inactive049.45185.1439-10.9187-3.6004-4.60710.015617.848513.801-6.53560.5436-3.981315.85290.99558.7778-0.51489.4518QC'd by BIOMOLInconclusive0.169342.502710Single point of activity-6.77133.92950.653739.4606
Inactive041.8471-10.88334.52062.79765.23563.9098-5.1881-2.0961-0.0954-3.919-3.2093-1.8064-33.7228-4.1242-0.88821.8471QC'd by BIOMOLInactive04.95490.31142.5
Inactive044.8349-4.63776.5338-3.86720.3182-6.07670.8186-2.79026.0128-0.779714.731111.52557.4133-0.9249-2.93594.8349QC'd by BIOMOLInactive04.95490.371213.3777
Inactive04-4.067912.1355-8.423722.677520.0333.0761-4.23854.78041.17568.42751.9834-7.49172.3009-2.1910.399-4.0679QC'd by BIOMOLInconclusive0.016923.312910Complete curve; partial efficacy; poor fit-7.77134.95490.334218.2886
Inactive042.05745.26574.3417-5.6188-2.5518-0.73413.2906-1.1924-0.81874.4295-6.552710.0188-0.8658-4.17642.45482.0574QC'd by BIOMOLInactive0
Inactive048.5616-2.0682-0.46498.21222.20687.6990.2449-0.087712.19887.0464-0.3008-1.4858-2.93310.76220.39078.5616QC'd by BIOMOLInactive0
Cytotoxic6.00796.604783Complete curve; high efficacy-5.22134.95490.9827-93.96262.6422-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-96.07621.3064-6.14065.13090.1256-0.83290.3014-0.60629.61044.55867.1299-0.84948.1454-69.6407-92.7982-96.0762QC'd by BIOMOLCytotoxic5.353889.607684Complete curve; high efficacy-5.27134.95490.9148-95.5166
Inactive04-3.2987-4.8177-8.49767.47813.7599.2959-2.2766-1.27941.7611-5.167216.38672.699710.28948.2038-9.5775-3.2987QC'd by BIOMOLInconclusive0.030119.213610Complete curve; partial efficacy; poor fit-7.52134.95490.332612.8869
Inactive048.7339-1.21470.07750.0749-2.3291-0.54618.96933.3015-2.1752-15.4981-13.43471.2297-0.91132.62215.99288.7339QC'd by BIOMOLInactive0